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SUMMARY 
A program of measurements was made to determine the spectral 
fluence distributions at locations of significance in a heterogeneous, 
hominoid phantom exposed to x rays in a manner simulating medical 
diagnostic radiology. The measurements were made with a specially 
constructed Nal(TJi) scintillation detector. The detector had a spher-
ically shaped active volume 0.6 cm in diameter. The resolution of this 
detector was five times worse than that of a more conventional NaI(T&) 
spectrometer. Resolution broadening and other distortions were removed 
from the observed pulse height spectra with a computer-coded, iterative 
unfolding technique. The performance of the spectrometer and the un-
folding scheme was assessed by comparing, in a few cases, the unfolded 
NaI(T£) spectra with spectra determined with a high resolution Ge(Li) 
spectrometer. 
The measurements were made in a physical model of an idealized 
representation of an average adult patient. The phantom was constructed 
of molded lucite shells filled with differing materials to simulate 
lung, skeletal, and soft-tissue regions. To provide count rates suitable 
for scintillation spectrometry, a therapy-type x-ray machine was 
modified to operate at low exposure rates. However, because of the 
inherent filtration of the therapy-type tube, the output spectra of the 
x-ray machine were somewhat different than spectra typical of medical 
diagnostic radiology. How well the spectra of a particular x-ray 
machine resembles the spectra of the x-ray machine used in this study 
may influence the applicability of the data presented in this study. 
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Spectral fluence distributions were determined at the testes, 
ovaries, thyroid, eye, heart, and two spine regions. X-ray beams 
simulating lower spine, full spine, abdominal, shoulder, upper gastro-
intestinal, pelvic, and chest examinations were employed at generating 
potentials of 60, 80, and 100 kVcp. The measured spectra were unfolded, 
and the results are presented graphically. The absorbed dose in soft-
tissue was calculated from each spectrum, and these results are. presented 
also. In addition, measurements were made to determine the effect of 
shielding on the spectrum and absorbed dose in regions of interest 
outside the useful beam. 
The absorbed doses determined from spectral measurements were 
compared with a few ionization chamber measurements and with the results 
of Monte Carlo calculations. The absorbed doses determined with the 
spectrometer were generally lower than those determined with the ioni-
zation chamber, but the agreement in all cases studied was +_ 16% or 
better. The absorbed doses determined at the testes, ovaries, and 
thyroid were compared with analogous calculations performed by the U.S. 
Bureau of Radiological Health. The agreement between the measured and 
calculated values was good when viewed in perspective with the inaccura-
cies in the experimental simulation, the differences between the 
experiments and the calculations, and the uncertainty in the Monte Carlo 
calculations due to poor statistics. For example, the calculations did 
not account for collimator scatter while the program of measurements 
demonstrated that collimator scatter contributed significantly to the 
absorbed dose to regions outside the useful beam. 
xvi 
In addition to showing the feasibility and shortcomings of in-
phantom spectrometry, the results of this study demonstrated the 
significance of collimator scatter. It is suggested that more study 
be given to this effect and to the benefit of shielding all body areas 
outside the useful beam. 
CHAPTER I 
INTRODUCTION 
In 1896 Wilhelm Conrad Roentgen made a public announcement of his 
discovery of x rays. Besides reporting many of the physical properties 
of x rays, he also showed that x rays could be used to take pictures of 
the bones inside a human hand. From the period immediately following 
Roentgen's discovery until the present, x-ray photography or radiography 
has been a wery valuable tool in the practice of medicine. 
However, shortly after the announcement of the discovery of x rays, 
there was evidence that x rays could be harmful also. Grube, a man who 
had been manufacturing Crookes tubes and studying the fluorescence of 
chemicals before Roentgen's public announcement, developed erythema and 
finally ulceration on the back of his hand. He sought medical aid 
twenty-three days after Roentgen's announcement (Mo67). Three months 
later, Dr. J. Daniels of Vanderbilt reported that one of his 
colleagues had lost his hair following x-ray examination of his skull 
(E143). Fourteen months after Roentgen's announcement, 69 cases of skin 
damage due to x rays were reported (Sc97). Thus from its beginning, the 
use of x rays on humans has had the potential to be both beneficial and 
harmful to mankind. 
Today in this country, the largest use of x rays or other ionizing 
radiation on humans is in the practice of medical diagnostic radiology. 
According to the estimates of the Advisory Committee on the Biological 
Effects of Ionizing Radiations (BEIR Committee) of the National Academy 
1 
2 
of Sciences, medical diagnostic use of x rays is by far the largest man-
made source of radiation exposure to the U.S. population. Further it is 
estimated that medical diagnostic radiology comprises 40% of the total 
U.S. population's exposure to all sources of ionizing radiation. 
Figure 1 shows a summary of the BEIR Committee's estimates for 1970 
(BEIR72). Although actual whole-body doses for individuals and average 
whole body-doses for subsets of the population may vary greatly from the 
estimates of average whole-body doses presented, clearly medical diagnos-
tic radiology is overwhelmingly the largest source of man-made radiation 
exposure and is definitely non-trivial in comparison to the U.S. popula-
tion's total radiation exposure from all sources. 
A major job of the health physicist is "...to prevent acute radiation 
effects and to limit the risk of late effects to an acceptable level 
(ICRP66)." In accomplishing this task, it is necessary that the health 
physicist quantify various aspects of radiation fields and relate his 
measurements to given radiation safety standards (Ri72). 
Any radiation field of one type (i.e., alpha, beta, neutron, photon, 
etc.) can be described by specifying its fluence distribution $(E, ft), 
where $(E, ft) is the number of particles of energy E per unit energy and 
with direction ft per unit solid angle. If $(E, ft) for one type of radiation 
is known at all points of interest in a radiation field, then in principle 
any quantity can be calculated. However, the early x-ray and other 
radiation researchers had neither a comprehensive knowledge of the nature 
of radiation nor the electronic and solid-state technology necessary to 
make spectral measurements as we know them today. So it is not surprising 
that the ability of x rays to ionize gases was the basis of the first 
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The quantity, exposure, defined as the amount of ionization pro-
duced by electromagnetic radiation in equilibrium with its secondary 
radiation in a reference amount of air, was formalized by the Inter-
national Commission on Radiation Units by its definition of the 
roentgen ,in 1928 (ICRU28). One of the earliest proposed radiation 
protection standards related biological effect to the exposure produced 
by an incident x-ray field (Mu25). As the energy of available x-ray 
beams increased and as other forms of radiation were discovered, it 
became obvious that quantifying a radiation field in terms of exposure, 
alone, was insufficient or inappropriate. When reporting x-ray exposure 
measurements it became common practice to include some information re-
lated to the energy spectrum, such as generating potential and filtration 
(Ri72). This technique of specifying the exposure together with limited 
spectral information is still used today by radiotherapists in calcula-
ting the internal distribution of energy deposited by external beams of 
photons (Jo69). 
Today exposure is defined as 
The quotient of dQ by dm where dQ is the absolute 
value of the total charge of the ions of one sign 
produced in air when all the electrons liberated by 
photons in a volume element of air having mass dm 
are completely stopped in air (ICRU71). 
Although this definition is the end product of several revisions 
made in order to remove ambiguities and to increase rigor, it describes 
essentially the same quantity that was defined in 1928. The special 
unit of exposure is the roentgen (R), where 1 R is exactly equal to 2.58 
-4 x 10 coulombs per kilogram. 
5 
Two other quantities are commonly used in quantifying aspects of a 
radiation field with respect to risk. One is absorbed dose, which is de-
fined as 
The quotient of de by dm, where de is the mean 
energy imparted by ionizing radiation to the 
matter in a volume element and dm is the mass 
of the matter in that volume element (ICRU71). 
_2 
The special unit of absorbed dose is the rad, where 1 rad equals 10 
joules per kilogram (or 100 ergs per gram). The other quantity, speci-
fically designed for radiation protection applications, is the dose 
equivalent, H, which is defined as, 
The product of D, Q, and N, at the point of 
interest in tissue, where D is the absorbed 
dose, Q is the quality factor and N is the 
product of any other modifying factors. The 
special unit of dose equivalent is the rem. 
When.D is expressed in rads, H is in rems 
(ICRU71). 
The quality factor is a weighting factor chosen, somewhat arbitrarily, to 
indicate the biological effectiveness of a given absorbed dose of differ-
ent types of radiation. For x-radiation the quality factor is chosen to 
be unity. The factor, N, is to allow for the effects of the distribution 
of absorbed dose in space and time. For external sources this factor is 
chosen to be unity. Although the concept has been criticized for its lack 
of physical basis, its imprecision, and the difficulty of its determination, 
the dose equivalent is used in the most general expression of risk (Ri72; 
Th75). 
For the purpose of having radiation protection units conform to the SI 
system of units, two other units have been introduced recently. The gray 
(Gy) is a unit of absorbed dose and is equal to 100 rads. The sievert (Sv) 
6 
is a unit of dose equivalent and is equal to 100 rems. However, since 
there is some uncertainty regarding the general acceptance and use of 
these units in the U.S., they will not be used in this text. 
It might also be noted that there is a loose correspondence between 
the exposure (measured in roentgens) of an x-ray field and the absorbed 
dose (measured in rads) to a small mass of muscle tissue placed in that 
field. The absorbed dose to muscle equals 95% +_ 2% of the exposure. This 
numerical correspondence is due to the size of the constants used in de-
fining the units and to the fact that the propensities of air and muscle 
per unit weight to absorb energy from an x-ray beam do not vary much rela-
tive to each other over a wide range of x-ray energies. However, the 
absorbed dose in bone may be greater than four times the absorbed dose in 
muscle or the exposure in air at particular energies within the range 
typically used in medical diagnostic radiology (J069). 
It is widely accepted, 
... that in the vast majority of cases, exposure to 
ionizing radiation results in an increase in the en-
tropy or disorganization of cell guidance provided 
(jy the vast library of information contained in the 
nucleus of a target cell, be it a somatic or germ 
cell. On this basis alone it is difficult to con-
ceive of the existence of a threshold or safe level 
of exposure to ionizing radiation (Mo71). 
On the other hand, it is obvious that in many cases (but not all), the 
use of medical diagnostic x rays provides great benefit to the patient. 
Estimates of risk are quantified in terms of the basic quantities and 
units outlined above. From the standpoint of decision making, it is 
unfortunate that there is no accepted method for quantifying estimates 
of benefit. 
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In 1972 the BEIR Committee published a report on the effects of low 
levels of ionizing radiation. After a "review and re-evaluation of exist-
ing scientific knowledge concerning radiation exposure of human popula-
tions," the BEIR Committee arrived at some "best estimates" of radiation 
risks (BEIR72). Estimates of the long-term effect of exposure of the U.S. 
population such that the average dose equivalent rate from all sources was 
170 mrem/year included: 
1. An incidence of 0.75% (per year) of serious genetic or 
partially genetic defects and 
2. An increase of 5% in the ill-health of the population 
(assuming that 20% of ill-health is proportional to 
mutation rate, a 20 rem doubling dose, and a 5 rem 
per 30 year reproduction generation). 
3. An increase of about 2% in the cancer death rate 
(about 0.3% in the overall death rate from all causes) 
(BEIR72). 
Although the estimates of exposure from medical diagnostic x rays and 
the estimates of effects of ionizing radition are filled with uncertainties, 
it is apparent that the effects are non-trivial. Morgan estimates that 
current medical diagnostic x-ray practice results in 4,100 to 78,000 deaths 
per year (Mo71). Unquestionably diagnostic radiology also saves many lives. 
The health physicist and the medical professional, although their manner and 
methods are different, are concerned with minimizing human suffering. The 
goal of reducing the adverse effects while maintaining or improving the 
quality of medical radiology should be actively pursued by both. Therefore 
it is not surprising that among the BEIR Committee recommendations are the 
following which concern, in whole or in part, medical diagnostic x-ray ex-
posure: 
1. No exposure to ionizing radiation should be permitted 
without the expectation of a commensurate benefit. 
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2. The public must be protected from radiation but not to 
the extent that the degree of protection provided re-
sults in the substitution of a worse hazard for the radi-
ation avoided. 
3. Medical radiation exposure can and should be reduced 
considerably by limiting its use to clinically indi-
cated procedures utilizing efficient exposure tech-
niques and optimal operation of radiation equipment. 
Consideration should be given to the following: 
1) Restriction of the use of radiation for public 
health survey purposes, unless there is a rea-
sonable probability of significant detection 
of disease; 
2) Inspection and licensing of radiation and ancil-
lary equipment; 
3) Appropriate training and certification of in-
volved personnel. Gonad shielding (especially 
shielding of the testes) is strongly recommend-
ed as a simple and highly efficient way to re-
duce the Genetically Significant Dose. 
4. Every effort should be made to assure accurate es-
timates and predictions of radiation equivalent dosages 
from all existing and planned sources (BEIR72). 
Partly due to the recent criticisms of the traditional, but accepted, 
dosimetric quantities, a new approach to radiation dosimetry has been pro-
posed (Hu74). In this system, time-dependent probabilities for a specific 
biological effect in a given species are operationally derived from basic 
aspects of the radiation field. In this formalism, the flux density, 
<j>(E,ft,r,T), is the general description of a radiation field present in (or 
* _). 
incident upon) a biological system or subsystem. The E, n, r, T indicate 
the energy, angular, positional, and time dependence of the field. 
P. .(t > T ) is the probability of observing the biological effect i_ in 
species j_ at any future time t > T. It is assumed that an operator exists 
such that: 
°ij * ( T ) = Pij (t > T ) (1_1) 
-V 
where the arguments E, n, r have been suppressed for convenience and where 
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0.. is the operator which links the field with effect i_ in species j_. 
i J 
Assuming that 0.. exists, equation (1-1) is merely the mathematical 
expression of assuming the principle of cause and effect. In practice, 
the operator 0.- might be very difficult to define accurately enough to 
make the solution of equation (1-1) feasible. 
A set of measurements made in a radiation field can be expressed as 
R(e, ft, r, T) where e is the energy deposited in the detector and the 
other arguments are as before. For some detectors, i.e. spectrometers, it 
is possible to deduce <j>, the general description of the radiation field. 
That is there is an operator, 0., characteristic of the detector, such 
that: 
0dR(e,ft,r,T) = <j>(E,ft,r,T) (1-2) 
is simply stating mathematically that the detector is a spectrometer. 
Equation (1-2) implies that an unfolding procedure such that the spe-
tral flux density distribution, <j>, can be deduced from the spectrometer 
measurements, R. Performing this unfolding with reasonable accuracy may 
be difficult or impossible. It often requires computer-programmed, iter-
ative methods and may lead to answers with large uncertainties (He74). 
Equation (1-3) can be derived from equations (1-1) and (1-2): 
0 ^ 0d R(e,ft,r,T) = Or.. R(ei,r,i) = P... (t > T ) . (1-3) 
If the operator, 0.., exists and can be adequately defined, then unfolding 
to find <j>(E, ft, r, T) is not necessary. Further, in principle, 0j. may 
be built into the electronics of a detector such that it reads probability 
of biological effect directly. Thus instead of using "rad-meters" or 
10 
"rem-meters", health physicists might have "cancer-meters" or "sickness 
meters." 
Hurst, Garrett, and Payne conclude their article by recommending 
that radiobiological experiments be" conducted in such a manner that the 
time-dependence of particular effects can be inferred and that radiation 
protection instrumentation research should "concentrate more on those 
methods which can characterize the radiation field" (Hu74). 
The objective of the research presented in this dissertation was the 
design, development, and application of a spectrometric dosimetry system 
for use in experiments simulating medical diagnostic x-ray exposure con-
figurations. The applications of the system v/ere to include: 
1. A demonstration of the feasibility of spectrometric 
dosimetry measurements. 
2. Determination of the values of various dosimetric 
parameters within an anthropomorphic phantom and com-




Production of X rays 
Energetic electrons colliding with atoms may generate x rays in 
one of two manners. When a collision causes a vacancy to occur in an 
inner shell of an atom's electronic structure and when that vacancy is 
filled by an electron transition from a higher shell, an x ray may be 
produced. The energy of the emitted photon is equal to the difference 
between binding energies of the initial and the final state of the 
electron undergoing the transition. Since the binding energies of the 
different levels are characteristic of each element, x rays so produced 
have an energy which is determined by the atomic number of the radiating 
atom and the particular transition which occurred. Such x rays are 
called characteristic x rays. 
An inner shell vacancy may also be filled by a nonradiative 
process. During the transition, the binding energy difference may be 
imparted to an outer shell electron, and thus no x ray is produced. The 
ejected outer shell electron is called an Auger electron. The probability 
of x rays being emitted from a vacancy in a particular shell is called 
the fluorescence yield (Ev 65). 
Characteristic x rays are labeled according to the initial and 
final states of the electron undergoing transition. X rays originating 
from vacancies in the K shell are called K x rays and are subscripted by a 
and 3 to indicate that the electron undergoing transition originated in 
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the L or M shell respectively. Further, numerical subscripts are used to 
indicate the particular sub-shell as needed. The energy of K x rays varies 
p 
roughly as (Z-l) , (where Z = atomic number) and for example, the K -, 
x ray of oxygen, sodium, iodine, tungsten, and lead are 0.52, 1.04, 
28.6, 59.3, and 75.0 keV respectively. The K-shell fluorescence yield 
increases as a monotonic sigmoid with increasing atomic number. The 
K-shell fluorescence yield for low Z elements, such as oxygen and 
sodium, are indeterminately small. Auger electron emission is the over-
whelmingly preferred process for such elements to fill an inner shell 
vacancy. On the other hand the K-shell fluorescence yield for 
iodine, tungsten, and lead are 86%, 94%, and 97% respectively (Le67). 
Swift electrons may also create x rays directly by inelastic 
collisions with atomic nuclei. As the incident electrons are deflected 
and decelerated by the Coulomb field of a nucleus, "braking radiation" 
or bremsstrahlung is emitted. For incident electrons with a given 
kinetic energy, E m a v, the energy fluence, ^(E), of the emitted max 
bremsstrahlung, in any particular direction is constant for E <_ E m a v 
max 
and zero for E > E . Hence the number of photons of a given energy 
(i.e., fluence, $(E)) varies inversely with that energy (Ev65). 
A rigorous theoretical treatment of the production of 
bremsstrahlung by electrons incident on a single atom requires theory 
from quantum mechanics. The treatment of the production of bremsstrahlung 
in targets of finite thickness must include a description of the transport 
of swift electrons in the target material. Because this transport is, in 
Energy fluence, ^(E), is defined as the product of the fluence, $(E), 
and the energy, E. 
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general, so complex, an exact theoretical treatment of x-ray production in 
"thick" targets is impossible. However, a simplified description based on 
semi-empirical and numerical methods, has been developed, and produces 
results which are in agreement with data determined by direct experiment 
(Ev65). The energy fluence, y, as a function of photon energy, E, is 
described by 
dv(E) « Z(Emax - E) dE (2-1) 
where E _ is the kinetic energy of the incident electrons and Z the max *J 
atomic number of the target. The shape of the energy fluence spectrum 
suggested by equation (1-1) is that of the sum of "thin" targets each 
being bombarded by electrons of decreasing kinetic energy (Ev65). Since, 
in practice, x-ray tubes must be enclosed, useful forms of equation (1-1) 
usually include a term which reflects the absorption of low energy pho-
tons by the tube housing. Then equation (1-1) becomes 
dv(E) « z(Emax - E) exp - y(E)d dE (2-2) 
where y(E) is an attenuation coefficient for the inherent filtration of 
the x-ray tube envelope and d is its thickness. The y(E) for various 
materials can be approximated by 
v(E) = A + ^ r (2-3) 
E 
where n>2 and A, C, and n are positive and are empirically determined. 
Thus the exponential term in equation (2-2) is rapidly decreasing below 
a particular value of E and causes the low energy end of the spectrum to 
have a "cutoff" (Jo75). 
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In addition to producing x rays, swift electrons produce much heat 
in an x-ray target via ionization and excitation interactions. The 
fraction, f, of total incident energy converted into bremsstrahlung in a 
thick target is approximately 
f = Z E(7 x 10"7) (2-4) 
where E has units of keV (Ev65). Tungsten, which has a high melting 
point and a large atomic number (Z = 74), is a common x-ray target material. 
According to equation (2-4) only 0.5% of the kinetic energy of 100 keV 
electrons incident on a tungsten target is converted into x rays. The 
other 99.5% is converted into heat in the target. Tungsten's high melting 
point protects against excessive target burnout. 
Interactions of X Rays with Matter 
X rays with energy in the range of 10 to 150 keV interact with 
matter in three major ways. The processes are photoelectric absorption, 
Compton scattering, and Rayleigh scattering. All three are interactions 
between photons and atomic electrons. Although photon interactions with 
nucleons, electric fields, and meson fields of nucleons are possible in 
some cases, such interactions for typical x rays are either energetically 
forbidden or insignificant in comparison with the electron-photon 
interactions. Pair production is an important interaction for photons 
with energies above 1.22 MeV but is energetically forbidden in the energy 
range typical of diagnostic x rays. 
In the photoelectric process an incident photon is completely 
absorbed by interacting with and ejecting one of the atom's orbital 
electrons. The kinetic energy of the ejected electron is almost entirely 
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the energy of the photon less the binding energy of the ejected electron. 
Although the rest of the atom recoils slightly in order to satisfy the 
conservation of momentum requirements, it has little kinetic energy 
imparted to it. The vacancy in the electronic structure of the atom is 
filled by a radiative or nonradiative process as discussed in the previous 
section. 
Compton scattering is a process in which a photon is deflected by 
an atomic electron. It can be considered to be a two-body process, since 
in cases where the binding energy of the struck electron is significant, 
photoelectric absorption is an overwhelmingly more probable interaction 
(Ev65). In a Compton process the energy and momentum of the incident 
photon are partitioned between the deflected photon and the struck electron 
Using the relativistic expressions for total energy and momentum, the 
following well-known equation can be derived. 
hv' _ 1 
l"K> 1 + a(l - COS 9) 
0 
(2-5) 
where hv and hv' are the energies of the initial and scattered photon, 
2 
a = hv /m c , and e is the scattering angle of the photon. The maximum 
energy transferred, T v, occurs when e = 180. The maximum fraction of 
max 
energy transferred can be written as 
max _ 1 /« c\ 
h ^ T - - 1 + (l/2a) (2"6) 
Thus a 10 keV photon may lose only 4% of its energy in a Compton inter-
action, while a 100 keV photon may lose 28% of its energy in single 
Compton scattering event. 
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Rayleigh scattering is a two-body process in which a photon is 
deflected by an atom as a whole, producing neither atomic excitation nor 
ionization. Analyzing such a collision by requiring conservation of 
relativistic momentum and energy, yields an equation homologous to the 
Compton equations, (2-5) and (2-6), except that a = hv /M c , where M 
is the rest mass of the atom. Thus a 50 keV photon incident on a hydrogen 
atom (M ^L 1837 m ) could lose at most 5 eV of its energy. More detailed 
analysis of the physics of Rayleigh scattering shows that Rayleigh 
scattering must be confined to small angles. For 100 keV photons inci-
dent on aluminum, more than half of the radiation is scattered less than 
15°. Thus Rayleigh scattering (or "coherent" scattering) removes negli-
gible amounts of energy from a photon field (Ev65). 
The quantification of the interaction of photons with matter in the 
simple case of a beam incident upon a slab usually leads to an exponential 
type equation of the form 
A = k e" B x • (2-7) 
o 
Equations of the form of (2-7) are used to compute photon fluence and 
flux density, energy fluence and flux density, and energy deposition 
and interaction site distributions. The coefficients and parameters of 
equation (2-7) are adapted to the particular situation being studied 
and the definitions of such parameters are given in many locations (ICRU71 
Ev65; Ro68a; Jo69; Mo67). Briefly, if A describes the photon fluence or 
flux density, A is the quantity before attenuation, B is the linear 
attenuation coefficient, y, and x is the depth into the material. 
Alternatively, B is y divided by p, (p = the density), is expressed in 
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terms of area per unit mass and is called a mass-attenuation coefficient. 
In this case the x term is the product of the depth and the density and 
has units of mass per unit area. Other common coefficients and param-
eters are explained in Table 1. 
There are several consequences of the fact that equations of the 
form of (2-7) are macroscopic descriptions of processes that occur 
between photons and electrons. First is the fact that interactions at 
the photon-electron level are independent (i.e., a photon may not interact 
photoelectrically and Compton scatter with the same atom). Thus the 
interaction coefficients can be broken down linearly, and the linear 
attenuation coefficient may be expressed as 
M = T + a + n (2-8) 
where x, a, and n are the partial attenuation coefficients for photo-
electric absorption, Compton scattering, and coherent scattering respec-
tively. Similarly if an absorber is made up of a number of elements of 
various atomic numbers, then the mass attenuation coefficient for the 
compound or mixture can be calculated by 
* = w, ^ + w9 * + w, * + ... (2-9) 
Material ] p l 2 p2 3 p3 
where w-,, w2> w~, ... are the fractional amounts by weight of each 
element, and the (y/p)'s are the respective attenuation coefficients of 
the elements in the absorber. 
A second consequence of the atomic scale of the interactions of 
radiation with matter is its statistical nature. Thus equations of the 
B y 
Table 1. Coefficients and Parameters of Exponential Attenuation Equations of the Form A = A e 
A and A Quantity 
Name, Symbol, Description 
B Coefficients 




fluence, $, photons/unit area 
flux density, <f>, -rr 
linear attenuation coefficient, y, per unit 
length 
mass attenuation coefficient, y/p, area/unit mass 
cross-section per atom, a or a, area/atom 
_ cross-section per electron, ga, area/electron 
x, length 
px, mass/unit area 
v „ /A atoms px n /A , —-; 
o ' u n i t area 
v„ 7/A electrons 
aXn Z/A, —rr— 
o u n i t area 
p = densi ty 
n = Avogadro's 
number 
A = atomic 
weight 
Z = atomic 
number 
Q„Q™w * i „«»„,.«» u, energy u " t l Mjr • ," j-"^v-» '» u n i t area 
Am 
energy flux density, i|>, -rr-
linear enerqv absorDtion coefficient, u . Der 
unit length ' en' " 
en mass energy absorption coefficient, -^-, 
area/unit mass p 
x. length 
px, mass/unit area 
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form of (2-7) only predict the expected values. The actual results of 
attenuation experiments will have a statistical variation which should 
follow Poisson statistics. The standard deviation of a set of measure-
ments of fluence is estimated by the square root of the mean value. When 
large numbers of photons are encountered in radiation fields (e.g., 1 mR 
7 2 
corresponds to a fluence of 3 x 10 photons/cm of 60 keV photons), 
statistical uncertainties are small. However, the statistical nature of 
radiation interactions gives a probabilistic connotation to the co-
efficients in equations of the form of (2-7). The magnitude of the cross 
section, a (area/atom as given in Table 1) is the probability that a photon 
incident upon a unit area containing one atom will interact with that atom. 
The mean range, X, of a photon in a material can be computed by 
r x e^ xdx , 
x - ' - l - I . (2-10) 
r0 e-
xdx 
Similarly, the thickness of an absorber necessary to reduce the incident 
intensity of a beam to one half its original value (often called half 
value layer, H.V.L.) is defined as 
H.v.L. = M = 0J93 # (2_11} 
For the purpose of discussion in this text, the description of the 
interactions of radiation with matter is limited to the photon energy 
range of 10 to 150 keV. The upper limit was chosen because common radio-
graphic techniques do not employ generating potentials above 150 kV. A 
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lower limit of 10 keV was chosen because photons of this energy or lower 
have a mean free path in tissue which is very small compared with the 
dimensions of the human body and the dimensions of most human organs 
(x = 0.16 cm in reference man soft tissue for 10 keV photons). However, 
the low energy (< 10 keV) photon interactions in tissue would be of 
interest in the study of the mechanisms of radiation effects in biological 
material. Figure 2 shows the values of the mass energy absorption co-
efficient and partial mass attenuation coefficients in tissue as a function 
of photon energy. A computer-coded formulation of equation (2-9) incor-
porating the elemental composition of reference man soft tissue (ICRP75) 
and published values of the partial mass attenuation coefficients for the 
elements (Mc69) was used to calculate the coefficients presented (St74). 
The data presented in Figure 2 shows the relative importance of 
photoelectric absorption and Compton scattering in soft tissue. For the 
purpose of discussion, the energy region from 10 to 150 keV is subdivided 
into three regions. Above about 55 keV, the Compton process is the most 
probable type of interaction in soft tissue and also is responsible for 
50% or more of the energy absorption by soft tissue from all processes. 
(For 100 keV photons Compton interactions in soft tissue are 57 times 
more probable than photoelectric interactions and account for 90% of the 
energy absorption.) Just below 30 keV photoelectric absorption is the 
most probable type of interaction in soft tissue and is the dominant mode 
of energy absorption. In the middle region from 30 to 55 keV, the Compton 
interaction cross section in soft tissue lis the largest, but photoelectric 
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Coherent scattering usually is ignored, dismissed, or discussed 
yery sketchily in most treatments of the interactions of radiation with 
matter (Ev65; Ev68, Fr66; Jo69, Mo67; Pr64). However, the magnitude of 
the coherent scattering cross-section in tissue is non-trivial compared 
with the magnitude of the Compton interaction cross-section for photons 
with energy between 10 and about 55 keV. The fact that coherent 
scattering causes negligible energy absorption in the energy range of 
interest usually is given as the reason for dismissing it from dosimetric 
discussions. Nevertheless, it is not obvious to this author that co-
herent scattering has an insignificant role in radiation transport, and 
the effect of coherent scattering is considered in the section of this 
text dealing with the tissue-equivalent design of the phantom. 
Monte Carlo Calculations 
In contrast to the simplicity of calculating the attenuation of a 
monoenergetic beam incident on a slab of matter, the solution of radia-
tion transport equations for the scattering (including multiple scatter-
ing) and absorption of photons in complex and inhomogeneous geometry 
(i.e., a human body) is difficult. In general, closed-form solutions are 
impossible. Monte Carlo calculations are one method of obtaining numeri-
cal estimates of the solutions of complex radiation transport problems. 
In such calculations, which in practice are usually done using a digital 
computer, a set of photon "histories" are generated one at a time, and 
the results are abstracted from the data provided by generation of the 
"histories ." In the simplest form of such calculations, each photon 
"history" is started by assigning the photon an initial position, direc-
tion, and energy. The distance that a single photon will travel into a 
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material before interacting is undeterminable. However, the probability 
distribution of the possible penetration distances is given by equations 
of the form of (2-7) with x being the distance of penetration, A = 1 , 
and B being the linear attenuation coefficient (y). In a Monte Carlo 
calculation, a photon can be "transported" by selecting a penetration 
distance according to this probability distribution and calculating the 
coordinates of the first interaction site. 
Since the probability distributions for absorption, scattering, 
and if applicable, scattering angle are known, the photon can be absorbed 
or scattered according to random selections from the appropriate probabil-
ity distributions. Thus a photon can be followed from its source until it 
either is absorbed or escapes from the region of interest (Ro68b). As a 
set of photon histories is generated, mean values of the amount of energy 
deposited in various regions, the number of photons crossing a certain 
boundary, or other quantities of interest can be accumulated. These 
accumulated mean values are estimates of the true mean values. 
According to sampling theory, statistical quantities such as 
variance and standard deviation can be used to estimate the reliability 
of their respective calculated sample means. The data needed to 
calculate the statistical quantities can be accumulated along with the 
mean value data. 
One statistic often calculated is called the coefficient of 
variation. This quantity is the standard deviation divided by the mean. 
It is dimensionless and is usually expressed in percent. Snyder has 
suggested that estimates of absorbed dose determined by Monte Carlo calcu-
lations would be expected to vary about the true mean by as much as twice 
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the product of the coefficient of variation times the mean (Sn70). Thus an 
estimate provided by Monte Carlo calculation with a coefficient of varia-
tion in excess of 50% should be considered unreliable. 
The drawback to Monte Carlo calculations is that although, in theory, 
the estimate of any mean value can be determined to any desired degree of 
reliability (by following a sufficient number of photons), in practice the 
number of histories that can be generated (limited by the amount of com-
puter time available) often does not determine an estimate with desired 
reliability. The generation of 200,000 histories is not uncommon. More 
sophisticated Monte Carlo calculations use variance reduction techniques 
such as weighting, splitting, and Russian roulette, that, although not 
directly analogous to physical processes, are statistically sound and im-
prove the reliability of the results (Ca75). 
In 1976 the U.S. Bureau of Radiological Health completed a study 
of the absorbed dose to several organs from common diagnostic x-ray 
exposure situations (Ro76a; Ro76b). The basis of this study was a set 
of 2,716 Monte Carlo calculations, of 30,000 photon histories each. The 
calculations were performed using an idealized anthropomorphic model 
described in subsequent chapters in this text,. Average absorbed doses 
were calculated for the thyroid, ovaries, testes, uterus, and active bone 
marrow regions. Because of the general nature of the model and because of 
the simplifying assumptions and methodology used to keep the number of 
calculations manageable, the results of the study were not intended to 
provide data pertaining to specific individuals. Rather, it was intended 
that the data be used "...to evaluate the effect on organ dose of changes 
in technical parameters in or among facilities" (Ro76b). 
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Phantom Measurements 
In addition to Monte Carlo calculations, it is possible to obtain 
data on the transport and absorption of an x-ray field in a material of 
complicated geometry by appropriate measurements. Obviously to determine 
the transport and absorption of radiation in humans by experiment, it is 
often necessary to use a substitute structure for reasons of safety, avail-
ability, and convenience. Traditionally, such a substitute is called a 
phantom. For satisfactory simulation it must scatter and absorb radiation 
in a manner similar to the biological material it represents. 
Early researchers used hollow anatomical models filled with water 
as phantoms (Qu37). Spiers, in attempting to find a dry substitute for 
water, developed a method for evaluating the equivalence of one material 
with another (Sp43). He defined a quantity called effective atomic 
number as 
Z = 2-94Vl V i 2 - 9 4 (2-12) 
where A. is the fraction of electrons for element Z., and the summation is 
over all elements in the compound. The effective atomic number reflects 
the change in photoelectric cross-section with Z. Since Compton scatter-
ing cross-sections per electron change little for low Z elements, 
materials with similar electron densities and with similar 1 would 
interact with radiation fields in a similar manner. 
In 1949, the development of a solid substitute for water was 
reported (Jo49). Using the above criteria to determine its equivalence 
to water, a substance of 60.8% paraffin, 30.4% polyethylene, 6.4% MgO, 
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and ZA% Ti Op which was easy to mold and machine and remained homogeneous 
was made. The material was called "Mix D," and its water equivalence was 
verified by experiment. Rectangular and human-shaped Mix D phantoms were 
used to assess the gonad dose from medical diagnostic x rays (St55; Ad57; 
El61; Yo67; Ta72). Data acquired from Mix D phantoms were used to assess 
the hazards to populations from medical x rays by the British and 
Japanese government commissions (Gr60; Ja61). 
Other water substitute phantoms were used also. Rectangular phan-
toms of "Pressdwood" (or Masonite) were used to estimate gonad doses (We57; 
Bi57; Ja67). Human-shaped pressdwood phantoms with a human skeleton in-
serted and with cork substituting for the lungs were used to measure bone 
marrow and gonad doses (La57; Ep61). Paraffin wax phantoms were used for 
similar measurements (Li58; Du68). All of these phantoms have the disad-
vantage that they are designed to be equivalent to water not tissue. For 
x rays with energy from 15 to 100 keV water has a 4% larger photoelectric 
partial mass attenuation coefficient and an 8% larger coherent scattering 
partial mass attenuation coefficient than reference man soft-tissue (St74). 
Yet for higher energy photons, for which Compton scattering is the pre-
dominant interaction, water and pressdwood are adequate and, their use is 
recommended (Jo69). This suitability of water phantoms for use in experi-
ments involving photons with energy higher than that typical of diagnostic 
radiology is not surprising. In this higher energy range Compton scatter-
ing in soft tissue is overwhelmingly the most important interaction and 
Compton scattering cross-sections are directly proportional to electron 
density. Excepting hydrogen, most elements found in tissue (Z < 20) have 
a similar electron density since their ratio of atomic number to atomic 
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weight is approximately constant (Z/A ^ 0 . 5 ) . Thus for energies above 
approximately 150 keV, materials which have a density and hydrogen con-
tent similar to tissue will absorb and scatter radiation via the Compton 
process in a manner similar to tissue. 
In contrast to the simplicity of tissue-equivalence for higher ener-
gies, the propensity of a material to scatter and absorb radiation with 
energy typical of diagnostic x rays is a complicated function of elemental 
composition. Further since the mean free path for photons in the diagnostic 
energy range is shorter than for higher energy photons, the tissue-
equivalence of a substitute material is more important. For example, a 
beam of 300 keV photons passing through 20 cm of soft-tissue (y = 0.111) 
would be attenuated to 11% of its original intensity. The same beam 
passing through 20 cm of a material with an attenuation coefficient 10% 
larger than soft-tissue would be attenuated to 9% of its original inten-
sity. Thus an increase of 10% in attenuation coefficient causes a 20% 
reduction in transmitted intensity for 300 keV photons incident on a 20 cm 
thick slab of soft-tissue. An analogous calculation for 30 keV photons 
(y = 0.316 in soft tissue) shows that an increase of 10% in attenuation 
coefficient causes a reduction of almost a factor of two in transmitted 
intensity. Thus, for photons in the diagnostic energy range, a small 
error in the tissue-equivalence may cause a large error in the absorbed 
dose measure at a point remote from the point of incidence of the beam. 
In 1966 the Alderson human-shaped inhomogeneous phantom was developed 
and made commercially available (A166). Phantoms of this type are com-
posed of a human skeleton imbedded in tissue-equivalent plastic. Lower 
density material for lung regions may be inserted optionally. The 
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Alderson phantom is sliced horizontally in two cm thick sections and small 
holes are located in each section to accommodate thermoluminescent dosim-
etry chips or miniature ionization chambers. Its manufacturers claim it 
is "soft-tissue equivalent," but due to the proprietary status of the 
tissue-equivalent plastic used, it is difficult to obtain exact information 
on its composition. Further since each human skeleton is different, each 
phantom is different and it has been observed by this author that some of 
these phantoms have skeletons that are too small for the exterior contours 
of the encasing plastic. Models of this phantom have been used for dosi-
metric studies of diagnostic x rays (Ha72, Va72). 
In assessing the state of the art of in-phantom dosimetry studies of 
the absorbed dose to organs of radiological interest, two shortcomings 
should be noted. First, much of the research discussed in the preceding 
paragraphs has little bearing on the question of somatic risk. Five of 
the eleven studies cited (St55; Aj57; Li58; Du58; El61) presented measure-
ments of gonad doses only. Four studies (La57, Ep61, Yo67, Ta72) pre-
sented some measurements of absorbed dose to bone marrow regions in addi-
tion to gonad doses, and one study (Ha72) presented bone marrow absorbed 
doses only. One study (Va72) employed x-ray film and thermoluminescent 
dosimeters "sandwiched" in between layers of a random phantom. However, 
the results presented in this study did little more than confirm the re-
sults of Epp ejt al_ (Ep61). Thus a vast majority of the studies cited 
presented data for only a few organs. A complete study relevant to 
somatic risk would have to have data for all radiosensitive organs. 
The second major criticism of previous in-phantom dosimetry con-
cerns the methods and apparatus used. It was not until the late 1950's 
29 
that the concept of absorbed dose was introduced and formalized officially. 
Because definitions were in a state of flux, it is often difficult to de-
termine exactly what quantity was measured in studies performed during 
this period. Also, some phantoms used in previous research were designed 
to be water-equivalent, not tissue-equivalent. The Rando phantoms used in 
some studies had undocumented tissue equivalence and variable skeletal 
geometry. As was discussed previously, tissue equivalence may be extremely 
important when one material is substituted for another. Mismatches of 10% 
(causing some absorbed dose measurements to differ by a factor of two) for 
equivalent maerials for use in diagnostic radiology experiments are not 
•inconceivable. Even ICRU muscle and reference man soft-tissue have mass-
energy absorption coefficients that differ by 7% for 30 keV photons. Thus 
materials equivalent to one standard composition will not be equivalent to 
another. In summary, the U.S. Bureau of Radiological Health, in looking 
for data from experiments with which to verify their calculations found 
that "few experimental data that have been obtained in a scientifically 
controlled manner are available with which to compare ..." (Ro76). 
Spectrometry studies using phantoms have been of several types. In 
1951 a study of the spectral distribution of scattered and unscattered 
radiation in a paraffin block phantom was made (Gr51). Using the data of 
other researchers, the change of exposure measured with a spherical 
air-equivalent ionization chamber surrounded with layers of spherical 
copper shells of various thicknesses was examined. Then the exposure rate 
as a function of wavelength for unscattered and scattered radiation at the 
surface and 10 cm deep in the block was computed. Obviously, this early 
work is of an approximate and preliminary nature. 
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In 1960 and 1967 similar experiments were performed in which a cylin-
drical tank of water was irradiated with a plane beam (Ma60; Ep67). A 
hollow lucite type was used to "extract" the spectrum of x rays from the 
center of the tank and transmit it to an external Nal(Tii) scintillation 
spectrometer. In both experiments the entire apparatus could be rotated 
about the axis of the cylinder so that the spectrum of x rays traveling in 
any direction could be measured. Since the tank was positioned horizon-
tally, it could be filled to any desired level and the spectrum could be 
measured at various depths from the surface. Both researchers observed 
that the unscattered (or primary) and the scattered spectra became "harder" 
(i.e., had a higher average energy) with depth, and as expected for inci-
dent spectra typical of medical diagnostic x rays, the scattered x-ray 
spectrum was "softer" than the primary. These experiments are the only 
reported attempts to measure the spectral fluence distribution inside a 
phantom exposed to medical diagnostic x rays. 
Several measurements have been made of the x-ray field scattered 
from a phantom exposed to x-ray beams (Tr72, Wa73, Str75). However, the 
purpose of these studies was to determine the half value layer or the 
average energy of the scattered radiation in order to design secondary 
shielding optimally. Their results are not relevant to the question of 
the spectrum inside a phantom exposed to diagnostic x-ray beams. 
Sodium Iodide Scintillation Spectrometry 
Of the many methods for measuring the spectral fluence of an x-ray 
field, sodium iodide scintillation spectrometry was chosen as the method 
for use in this project. Despite its inferior resolution, scintillation 
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spectrometry was selected because it allowed a wide latitude in choice 
of detector size and shape. Sodium iodide was chosen, in particular, 
because of its high intrinsic efficiency. 
The scintillation process in sodium iodide activated with thallium 
can be described in three steps. An energetic electron set in motion by 
an x-ray interaction moves through the crystal until it dissipates all 
of its energy by ionizing and exciting other electrons. Some of these 
electrons (and their resultant holes) migrate to the thallium impurity 
centers. Some of these excited impurity centers de-excite in a radiative 
process. Thus, if the physics is understood (or if the end result is 
known as a function of the initial conditions), the light emitted from 
the scintillator in a particular band of wavelengths can be related to 
the kinetic energy of the energetic electron and, ultimately, the x ray 
which initiated the process. For NaI(T£) the emission band is centered 
around 420 nm and the decay time for the scintillation process is about 
3 x 10" sec. Further the light production in NaI(T£) is linear with 
respect to initial electron energy for the range of energies of interest 
to spectrometry of x rays (Pr64). 
To complete the scintillation spectrometry process it is necessary 
only to collect the light produced by the scintillator, measure it, and 
allow for distortions and fluctuations that may occur. A light pipe in 
optical contact with the crystal is used to bring the light (or at least 
a fraction of the light) to the photocathode of a photomultiplier tube. 
The light impinging on the photocathode produces a pulse of electrons. 
This original pulse is amplified by an electron multiplication process in 
the photomultiplier tube. A preamplifier is used to convert the pulse of 
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charge produced by the photomultiplier tube into a voltage pulse. The 
voltage pulse can be shaped and amplified by appropriate electronic 
circuitry. An analog-to-digital converter is used to digitize the magni-
tude of the voltage pulse. Thus a spectrum of x rays incident upon the 
scintillator will produce a spectrum of pulse heights. A multi-channel 
analyzer is used to display and record the pulse height spectrum. 
A measured pulse height spectrum can be related to the spectrum of 
incident x rays by the operator equation 
R(N,6) = 0d 4>(E,n,r,t) (2-13) 
where <j>(E,n,r,t) is the spectrum incident on the detector, R(N,6) is the 
response of the detector system, and 0 . is the operator, characteristic 
of the detector system, which relates the two. R(N,5) is a collection 
pulse height spectra with N being channel number, and 5 is a dummy variable 
to indicate that for a given incident x-ray spectrum, a distribution of 
pulse height spectra would be expected. Equation (2-13) can be simplified 
if certain conditions are met. If the rate at which x rays interact 
with the scintillator is slow compared with the rate at which the spec-
trometry system can measure and catalogue the energy of the x rays, the 
time dependence of equation (2-13) can be ignored, and the spectral flux 
density can be replaced by the spectral fluence. Similarly if the spatial 
and angular dependence of the spectral fluence with respect to the detector 
are constant or if the response of the detector is independent of the 
angular and spatial distribution of the field incident upon the detector, 
these variables can be ignored. In this case equation (2-13) simplifies 
to 
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R(N,6) = Od cf>(E) . (2-14) 
Obviously, for an ideal detector, 0 . = 1 and the inversion of equation 
(2-14) is trivial. However, real scintillators have distortions and un-
certainties which make both 0d and its inverse more complicated. 
The operator, 0 ., must account for the difference between the 
incident x-ray spectrum and the spectrum of energy deposited in the active 
volume of the crystal. Further, 0. must account for any nonlinearities 
in the scintillator's conversion of ionization and excitation into 
scintillated light and for any nonuniformity in the collection of such 
light. Finally, 0., must incorporate the statistical nature of the photo-
multiplier's performance. Typically, for an input pulse of light falling 
uniformly on the photocathode, the electronic output pulse will be any 
one of a distribution of output pulses. The distribution of output 
pulses is Gaussian with both the mean and the variance of the distribution 
being proportional to the intensity of the light pulse. 
To do spectrometry, equation (2-14) is not important but rather 
its inverse 
•(E) = 0"1 R(N,6) (2-15) 
is the equation which must be solved. It is agreed (He74; Wa72) that 
equation (2-15) is ill-conditioned and the direct inversion of the 
operator, 0., to find 0"j is not feasible. Further, by a series of 
measurements it is impossible to determine R(N,6), the entire distribution 
of possible pulse height spectra. Therefore, the unfolding "problem" is 
to determine approximately the incident x-ray spectrum given one or a 
few pulse height spectra. 
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The method used to deal with the unfolding problem in this work is 
an iterative, numerical method. As will be discussed in Chapter III, the 
response of the detector was determined for uniformly incident mono-
energetic beams of photons. The response functions Rr (N), Rr (N), 
t1 t2 
RF (N), ..., were determined for E, = 10, 12, 14, ..., 130 keV. Then for 
b3 ' 
an observed pulse height spectrum, R(N), a suitable linear combination 
was found such that 
|A]RE (N) + A2R£ (N) + A3R£ + ... - R(N)| <_ G(N) (2-16) 
where G(N) is an acceptable error distribution. A computer-coded, 
iterative successive approximation technique was used to select the 
appropriate linear combination (Mc72). The details of the unfolding 
process and the determination of G(N), the acceptable error distribution 
are discussed in Chapter III. Obviously 
•(E) = A1E] + A 2E 2 + A 3E 3 + ... (2-17) 
is an approximate solution of equation (2-14). 
CHAPTER III 
APPARATUS AND PROCEDURES 
An x-ray facility, a spectrometer, and a phantom were necessary 
to perform the in-phantom spectrometry measurements in a manner which 
simulated diagnostic medical radiology. Also needed were the electronics 
ancillary to the spectrometer and a computer-coded unfolding procedure. 
X-Ray Facility 
It was deemed necessary that the x-ray facility meet the following 
criteria: 
1• Size. The shielded enclosure had to be large enough so that 
spectrometry measurements could be made with minimum scatter 
from shielding walls. 
2. Wide range of operating capabilities. To facilitate 
collection of spectrometry data when the point of measurement 
was far from the incident beam and the intensity of the x-ray 
field was greatly reduced, the x-ray machine had to be capable 
of sustained output over periods on the order of 1000 seconds. 
To be able to collect data with the spectrometer actually in 
the incident beam, the x-ray machine had to be capable of 
operating at tube currents on the order of 1 yA. 
3. Simulation of diagnostic x-rays. The x-ray machine had to 
have characteristics, such as inherent filtration and range 
of generating potentials, similar to those typical of 
diagnostic x-ray machines. 
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4. Stability and regulation. The x-ray machine had to have good 
voltage regulation for the wide variations in tube current. 
It had to be a constant potential type machine with minimal 
high voltage ripple to ensure that the high voltage wave form 
had little variation over the wide range of tube currents. 
The x-ray machine output had to be stable and reproducible. 
Since an x-ray facility meeting the above criteria was not avail-
able, it was necessary to design and construct one. Figure 3 shows the 
layout of the facility, the shielding necessary, and some of the features 
of the safety interlock system. It was felt that neither a conventional 
diagnostic nor a conventional therapy x-ray machine would provide adequate 
stability and the wide range of operating capabilities needed. In general 
diagnostic x-ray machines are designed to operate at high tube currents 
(on the order of hundreds of milliamps) for short exposure times. Therapy 
x-ray machines are designed to operate continuously but with tube currents 
between 1 and 20 mA. Therefore, a cathode-near-ground x-ray machine con-
figuration was devised (see Figure 4), and a therapy-type x-ray machine 
was modified extensively to conform to this design. The cathode-near-
ground configuration is opposite from the conventional anode-grounded 
scheme employed in many diagnostic x-ray machines. 
The x-ray tube, tube housing, supporting stand, collimator, and oil 
cooler were parts of a Siemens 250 kV therapy x-ray machine. A therapy-
type-tube was chosen so that the x-ray machine could be operated contin-
uously for as long as necessary to measure the spectra at locations 
remote from the incident beam. However instead of being operated in the 
bi-polar mode, the anode was operated at positive voltage, and the cathode 


















-, v///////////////// rrrA 
0 ROTATING MAGENTA BEACON 
DO SPEAKER 
A MICROSWITCHES 
» EMERG. "OFF" PUSHBUTTON (MUSHROOM HEAD) 
7 KEY INTERLOCK 
INTERIOR 20'x 20' 
PRIMARY SHIELD 16" CONCRETE .. \xfl. U | r u 
SECONDARY SHIELD 8" CONCRETE OR %" Pb/ ° n , o n '8 







+ ^ FILAMENT 
POWER SUPPLY 




V W + \ R3 * \Z 
R 2 * U1 ̂ M VVVL + 
rVv\/ V W t - / ^ 1/1 
x







Figure 4. X-Ray Machine Schematic 
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The positive high voltage was provided by a vacuum-tube regulated 
supply capable of 20 mA up to 75 kV and 10 mA up to 150 kV. In this 
commercially available supply, an internal resistance chain provided 
feedback such that the voltage drop through the vacuum tube was 
continuously adjusted to provide a constant potential output. After pro-
curement of the voltage supply, it was tested to ensure that it met the 
contracted specifications. During this testing the high voltage com-
ponents were suspended in air, and the supply was operated at voltages 
up to 40 kV. A series of high voltage resistors were used to provide a 
test load that would draw approximately 3 mA at 40 kV. An oscilloscope 
was used to observe the shape of the high voltage waveform. The root-
mean-square value of the ripple in the high voltage waveform at 40 kV was 
observed to be approximately 0.05%. Later, the output voltage, digitally 
selectable, was measured with a 1000 megohm, temperature-compensated 
voltage divider in parallel with the x-ray tube. The voltage divider was 
calibrated to an accuracy of 1%. The selected output voltage agreed with 
the measured voltage within the 1% accuracy of the voltage divider. This 
agreement was checked for all operating voltages used in subsequent 
experiments and for currents from full load to the current drawn by the 
voltage divider (nominally 0.1 mA). An increase in output voltage of at 
most 0.3% was observed when the tube current was varied from full load 
(10 mA) to minimum load (1 yA). 
The circuitry to control the tube current is pictured schematically 
in Figure 4. Operational amplifier Ul controls the filament current 
power supply by comparing the voltage developed by the tube current 
passing through Rl with the voltage provided by the reference voltage 
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supply. Operational amplifier U2, its feedback capacitor, and input 
resistors prevent the relatively fast operational amplifier circuitry 
from over-regulating the slower filament,. Typically time constants from 
one to ten seconds were necessary to prevent tube current oscillations. 
The integrator measures the tube current and serves as a timer via its 
trip control. 
The output of the x-ray machine was calibrated with a Victoreen 
Radocon III ionization chamber and electrometer dosimetry system. The 
3 
two chambers employed for these measurements had volumes of 32.6 cm and 
3 
326 cm , respectively. The dosimetry system including probes was cali-
brated by the manufacturer with filtered x-ray beams with effective 
energies of 15, 21, 32, 34.5, 42, 50, 64, 84, and 140 keV. The measured 
exposure rate as a function of generating potential is shown in Figure 5. 
It is a rule of thumb that the exposure rate of a diagnostic x-ray machine 
should vary proportionally with the square of the generating potential 
(Ch70). The reference line with a slope of 2.0 in Figure 5 shows that the 
exposure rate of the x-ray machine follows this rule. Also the exposure 
rate was measured over the entire range of tube current (see Figure 6). 
At a given generating potential the variation of exposure rate per unit 
tube current was generally less than the +2% accuracy claimed for the 
Radocon III. The horizontal dashed lines in Figure 6 are not "best fit" 
but are presented for reference only. 
It was necessary to use the 32.6 cm chamber for tube currents 
above 3 mA and the 326 cm chamber for tube currents of 3 mA and below. 
3 3 
At 3 mA the 32.6 cm chamber measured 1% higher than the 326 cm cham-
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measured for tube currents from 5 to 15 mA are merely artifacts due to 
the difference in sensitivity of the chambers. It is not known whether 
indicated decreases in exposure rate measured for tube currents below 
10 yA are due to a change in sensitivity of the dosimetry system or are 
due to an actual decrease in the output of the x-ray machine. Neverthe-
less, since all variations are less than +_ 3%, it was decided to treat 
all subsequent data as if the output of the x-ray machine as a function 
of tube current was essentially constant. 
The spectral output of the x-ray machine was measured using a 
Ge(Li) spectrometer. The spectrometer had an active depth of 7.1 mm and 
a 0.25 mm beryllium window. The resolution of the Ge(Li) spectrometer 
was determined to be 0.9 keV full-width at half-maximum (FWHM) for a 
241 
60 keV photon ( Am). Since the magnitude of the resolution was small 
compared with the width of the spectra to be measured, it was felt that 
no corrections for the Gaussian broadening of the Ge(Li) spectrometer 
data were necessary. However it was advised that the counting rate at 
which the spectrometer was used be kept less than 1,000 counts per 
second to avoid degrading the resolution (Be76). Several steps were taken 
to limit the counting rate. The spectrometer was positioned 3 m from 
_3 
the x-ray tube target, and a collimator with an aperture of 7.7 x 10 
2 
cm was placed directly in front of the spectrometer. Spectra were 
measured for 60, 80, and 100 kVcp generating potential with tube currents 
2 
of 25, 10, and 6 yA, respectively. These measured spectra are presented 
graphically in Figures 7, 8, and 9. The raw data spectra shown are the 
2 
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Figure 7. X-Ray Machine Output Spectrum Measured with a Ge(Li) 
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Figure 9. X-Ray Machine Output Spectrum Measured with a Ge(L1) 
Detector — 100 kVcp. 
47 
pulse height spectra acquired with the Ge(Li) detector. To facilitate the 
comparison of these spectra with the spectra acquired with the NaI(T£) 
spectrometer described in the next section, the data were grouped into 
"bins" 2 keV wide as follows. The raw data were corrected channel by 
channel to account for intrinsic efficiency losses due to the finite thick-
ness (7.1 mm) of the Ge(Li) detector. Next, the fluence in any "bin" was 
taken to be the average value of the corrected counts in the raw data 
channels whose energy lay within the boundaries of the "bin." Both the 
raw data and the "binned" spectra shown in Figures 7, 8, and 9 have been 
normalized so that their integrals have the arbitrary value of 1.0 photon/ 
cm . 
The absorption edge prominent in all three spectra is centered at 
37.4 keV. This edge was caused by barium contained in the glass envelope 
of the therapy-type tube, and a similar barium edge has been observed by 
other researchers studying the spectrum of a similar tube of the same 
brand (Gi75). An approximate calculation showed that 0.016 gm/cnr 
(+. 10%) of barium was necessary to produce an edge the size of the one 
pictured in Figure 9. If it is assumed that the glass envelope is 
0.1 cm thick where the x rays exit the tube and that the glass com-
prising the envelope has a density of 3.0, then the barium content of 
the glass is approximately 5% by weight. Barium oxide is one of the 
materials added to glass to adjust its thermal expansion coefficient. 
Glass used to make x-ray tubes must have a thermal expansion coefficient 
similar to the metal components which penetrate the glass envelope in 
order that adequate glass-to-metal high vacuum seals can be made. The 
amount of barium added to x-ray tube glass varies from manufacturer to 
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manufacturer and from one batch of glass to another produced by the same 
manufacturer (Si77). 
Figure 10 shows the comparison of the 80 kVcp spectrum measured in 
this study (Figure 8) with a measured spectrum reported by Atkins as 
"representative of those used in diagnostic radiology" (At75). This 
reported 80 kVcp spectrum was produced with a beryllium-windowed x-ray 
tube with 2 mm of aluminum added filtration. According to some pre-
liminary and unpublished data furnished by researchers working in the 
Nationwide Evaluation of X-Ray Trends (NEXT) study, almost all diagnostic 
x-ray tubes have glass windows (Si77). However, according to the results 
of their unfinished study of spectra from six diagnostic x-ray tubes, 
none of the six tubes contained enough barium to noticeably alter the 
spectrum. Thus, the spectrum reported by Atkins is probably "more 
typical" of an 80 kVcp spectrum with 2 mm aluminum filtration than is the 
spectrum measured in this study (Figure 8). The effect of the differ-
ence between the spectral distribution of x rays employed in this study 
and the spectral distribution of x rays more typical of diagnostic radi-
ology is discussed in the Error Analysis section of Chapter IV of this 
text. 
The focal spot of the x-ray tube was determined to be 8 mm by 
8 mm. The determination was made using a 0.5 mm pinhole collimator and 
photographic film. The accuracy of the light localizer of the collimator 
of the x-ray machine was checked also with photographic film. The colli-
mator was of the variable therapy type in which a rectangular x-ray 
beam is formed by the two orthogonal pairs of shutter plates. A penumbra 
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Figure 10. Comparison of X-Ray Machine Output Spectrum with a 
Representative Diagnostic X-Ray Spectrum. 
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machine collimator. At a focal-spot-to-film distance of 1 m the penumbra 
was 0.75 cm wide. A typical diagnostic x-ray machine, having a smaller 
focal spot (1 or 2 mm square), would have a correspondingly smaller 
penumbra. 
In summary the x-ray machine met or exceeded all of the design 
criteria except that concerning the simulation of diagnostic x-rays. 
The shape of the spectrum of radiation produced by the x-ray machine 
only approximates the spectral shape typical of a diagnostic x-ray 
machine. Also the large focal spot and accompanying penumbra are 
several times larger than those typical of diagnostic x-ray machines. 
In order to be a better simulation, a tube with low barium content in 
the glass and with a smaller focal spot would be needed. Nevertheless 
since a better x-ray tube was not readily available, the above x-ray 
machine was used to complete the study. It was felt that the size of 
the penumbra would not affect the results of this study drastically. On 
the other hand because the spectral shape of the radiation produced by 
the x-ray machine does not simulate closely diagnostic x-ray spectra, care 
should be used in interpreting and applying the data presented in this 
study. 
Spectrometer 
A spectrometer that was compact, had a uniform response over 
all solid angle, and was capable of being used in a fluid-filled anthro-
pomorphic phantom was desired. A Nal(Tl) scintillation spectrometer 
meeting or coming close to these criteria was designed and is shown in 
Figure 11. The scintillation crystal was to be a sphere of 6.3 mm 
diameter which was half-imbedded in a polyvinyl toluene light pipe. 
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Figure 11. Nal (Til) Scint i l lat ion Detector. 
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The light pipe was to be optically coupled to an RCA 4516 photomultiplier 
tube. The scintillator and light pipe were to be covered by a 1.6 mm 
thick beryllium cap. The phototube and its ancillary voltage divider 
were to be covered with a magnetic shield, and the entire probe was to be 
hermetically sealed. 
After some difficulty and delay, two probes resembling this 
design were procured. A major deviation from design specifications was 
that the detectors accepted have scintillation crystals that were 
slightly oblate. As determined by radiographs, the diameter of each 
! crystal, parallel to the axis of the light pipe was 5.7 + 0.1 mm and the 
! 
! 
j diameter perpendicular to the axis of the light pipe was 6.2.+, 0.1 mm. 
One of the probes had a polished Nal crystal, and both the crystal 
and light pipe were covered with a specularly reflecting, thin aluminum 
| foil. The other probe had a crystal with a roughened surface, and, in 
i 
] this case, both the crystal and light pipe were covered with a diffuse 
| reflector (white paper). The detector with the unpolished crystal and 
1 diffuse reflector exhibited a slightly better resolution and was selected 
| for use in this study. 
I A third probe was procured also. This probe was similar to the 
M 
N others except that the Nal crystal was not included. This probe was used 
i in a preliminary set of measurements to determine the significance of 
L scintillations in the polyvinyl toluene light pipe and x-ray inter-
t 
M actions in the photocathode and first dynode. The investigations revealed 
! that such interactions were insignificant. In fact, no counts above the 
i lower level discriminator were observed when the blank probe was exposed 
[ in situations identical to those in which the regular probe was used to 
: acquire data. 
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The magnetic shielding for the probe used in this study was found 
to be inadequate early in testing of the detector. Orientation of the 
probe with respect to the earth's magnetic field influenced the gain of 
the photomultiplier tube by as much as ^ 10%. This problem was alleviated 
by wrapping the photomultiplier tube housing with several layers of 
"mu-metal," an alloy of high magnetic permeability. 
Two sets of measurements were performed to determine the uniformity 
of response of the detector with respect to orientation of the beam of 
impinging photons. Three sources were used: Co (122 keV gamma ray), 
Am (60 keV gamma), and Cd (Ag x-rays with average energy of 
22 keV). The orientation of the beam of photons was defined by a 
celestial coordinate system with the plane of the equator passing through 
the center of the spherical crystal perpendicular to axis of the light 
pipe. In the first set of measurements data were acquired for sources 
positioned at various azimuths in the plane of the equator. For each 
source no significant change in pulse height distribution was observed. 
In the second set of measurements, the sources were positioned at 
locations having varying declinations but a constant azimuth. The mean 
of the pulse height distribution varied as a function of declination and 
energy as shown in Figure 12. This variation is believed to be a result 
of changing light collection efficiency. It should be noted that the 
mean of the pulse height distribution varies less than 10% over the 
large solid angle contained between declinations of j^45°. This solid 
angle is 70% of 4TT steradians. Obviously, any photons passing through 
the photomultiplier tube housing would have a high probability of being 
absorbed there. However, since the housing subtends a solid angle of 
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Figure 12. Change 1n Mean of Pulse Height Distribution as a Function 
of Declination and Energy of Incident Beam (Data are 
Normalized so that Side Response Equals 100%). 
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less than 2.5% of the total solid angle viewed by the Nal crystal, 
effects of this nonunifortuity can be minimized by careful positioning of 
the probe within an ambient x-ray field. 
Next the resolution and linearity of the detector were determined 
as a function of incident energy. Measurements were made for side 
incidence with photons from isotopic sources and with monochromatic x-
rays. The mean and standard deviation of a pulse height distribution 
were determined by using a computer-coded least squares algorithm to fit 
a Gaussian to the multichannel analyzer data. 
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Sources of Co and Am were used as before and a Cd source, 
shielded with copper foil, was used to produce 88 keV photons. Mono-
energetic sources from 15 keV to 50 keV were produced using a bent 
crystal NaCl x-ray monochromator. The NaCl crystal used had a rocking 
angle of 0.1°. 
Since an 0.1° collimator slit was used to enhance the production 
of a highly monochromatic beam, the line source output of the mono-
chromator was not large enough to expose the entire active volume of the 
detector. Therefore, the response of the detector was determined in the 
following manner. Seven zones of a sphere were chosen so that each 
zone had an equal projected area. The detector was exposed to the mono-
chromatic source and the mean and standard deviation were determined at 
seven locations along the long axis of the detector. The seven 
locations were centroids of the projected areas of the seven zones. The 
mean of the pulse height distribution for a uniform side irradiation was 
taken as the average of the means measured at the seven locations. The 
corresponding standard deviation was computed after noting that the 
56 
variance of a sum of distributions is equal to the variance of the means 
plus the mean of the variances of the distributions comprising the sum. 
The results of linearity and resolution measurements are presented 
graphically in Figures 13 and 14. The linearity data was analyzed in 
two regions, the region above 32 keV and the region below. The discon-
tinuity at 32 keV is believed to be due to a variation in light collection 
efficiency for scintillations resulting from x-rays with energy near the 
57 
K-edge of iodine. The 122 keV point from the Co source and the 35 keV 
point from the x-ray monochromator were judged to be the most accurate 
and were used to determine the line representing the linearity in the 
upper region. The 30 and 20 keV points were used to determine the linear-
ity in the lower region. The line in the resolution graph (Figure 14) was 
57 
determined by a "visual best fit." Again the Co point was judged highly 
reliable. Note that the resolution of this detector is not as good as the 
resolution of a more conventional Nal spectrometer. The resolution of 
this detector, expressed as the ratio of full-width at half-maximum (FWHM) 
to the mean, was found to be 52% at 122 keV. The corresponding resolu-
tion (FWHM) for a 7.6 cm x 7.6 cm (dia.) NaI(T£) spectrometer would be 
about 12% (Is71). 
The equipment ancillary to the Nal (Til) spectrometer included a 
preamplifier, a linear amplifier and a multichannel analyzer. The 
preamplifier was designed by Thorngate (Th76). The multichannel analyzer 
had 1024 channels and a 100 MHz digitizing rate. To facilitate data 
handling, the analyzer was interfaced with a teletype equipped with a 
paper tape punch. 
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Figure 13, Mean of Pulse Height Distribution versus Energy for the 
Spherical NaI(T£) Detector. 
1 1 1 1 
_ DETECTOR RESOLUTION 
^ w — 










15 30 60 120 
ENERGY (keV) 
Figure 14. Sigma of Pulse Height Distribution versus Energy for the 
Spherical Nal(TJl) Detector. 
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Unfolding Procedure 
The unfolding scheme outlined by Equations 2-16 and 2-17 requires 
a complete set of response functions {Rr (Nk)} where E. is the energy of 
j 
the uniformly incident monoenergetic beam and the argument N. denotes that 
each function is a distribution over channel number. To obtain a set of 
response functions, the first step was the computation of the set of 
deposited energy distributions {RV (Ek)} where E. again indicates the 
j 
incident energy and the argument E. denotes that each function is a 
distribution over energy. A photon entering the detector may (1) escape, 
(2) be photoelectrically absorbed, or (3) be Compton or coherently 
scattered. Since coherent scattering does not result in any appreciable 
energy absorption it was not considered in this treatment. 
After a photon is photoelectrically absorbed, it may give rise to 
a fluorescent x ray. The fluorescence yield of sodium is small (3%). 
In addition, the low energy sodium fluorescence x-rays would have a ^jery 
short mean free path in sodium iodide. Therefore, sodium fluorescence 
also was not considered in this treatment. However, the fluorescent 
yield of iodine is quite high (86%) and the K and K groups of x-rays 
have average energies of 28.5 and 32.5 keV, respectively. Since the 
emission of a fluorescent x ray is isotropic, the probability averaged 
over all solid angle of a fluorescent x ray produced at a location r 
escaping from a spherical crystal is 
u(r0 + r) 
P ( r ) = ^ e u sinh(yr) + y ( r ^ - r') j V <*x (3-1) ^ e"yr° sinh(yr) + y(r* - r2) j ^ 
y(rQ-r)
 X 
where y is the linear attenuation coefficient, r is the radius of the 
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sphere, r is the vector which locates the point of fluorescent x-ray 
production with respect to the center of the sphere, r is the magnitude 
of r, and sinh is the hyperbolic sin function. 
Photons which are Compton scattered within the spherical crystal 
cannot be treated so simply. Although the energy-angle relationship for 
Compton scattering is not too complex (see Equation 2-5), the 
scattering is not isotropic. The probability for scatter in a given 
direction with respect to the direction of the photon before scattering 
is given by the Klein-Nishina relation (Ev65)„ The Klein-Nishina relation 
is exact but does not lend itself to integration in a complex calculation., 
Also, since Compton-scattered photons may be multiply scattered before 
escaping or being absorbed, it was decided to calculate the deposited 
energy distributions with Monte Carlo techniques. 
The distributions of energy deposited in a spherical crystal of 
Nal for incident monoenergetic beams of 10, 12, 14, ..., 130 keV were 
calculated. The results of the calculations for each incident energy 
were grouped into energy "bins" which were 2 keV wide. Figure 15 shows 
the results of the calculations for one of the 61 incident energies. 
The peak at 110 keV indicates the "full energy peak." The peaks at 78 
and 82 keV indicate events in which a K or K iodine x ray escaped 
the Nal crystal. The distribution below 36 keV indicates events in 
which a Compton scattered photon escaped the detector. Next the 
{R* (E,)} were converted to {Rc (N.)} by using the resolution and 
Ej k Ej k 
linearity data acquired as described in the previous section of this 
chapter. Figure 16 shows the response function for the same incident 














RESULTS ARE DIGITIZED FOR 2 keV WIDE 
ENERGY BINS AND ARE NORMALIZED 
PER UNIT INCIDENT PHOTON 
20 40 60 80 
ENERGY (keV) 
100 120 
Figure 15. Calculated Distribution of the Energy Deposited 1n the 
Nal Crystal of the Detector by a Uniform Parallel Beam 
of 110 keV Photons. 
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Figure 16. Calculated Response Function for 110 keV Uniformly 
Incident Photons. 
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The fluence, $(E), was computed from the observed pulse height 
spectrum, R(N), with a computer-coded, iterative technique. The 
technique has three basic steps: 
1. A trial pulse height spectrum R,-(N. ) was calculated with 
w = £ v i ( E j > x R E < N k ) (3_2) 
j 
j 
where the subscript i_ indicates the iteration number, *. 1 
is the estimate of the fluence resulting from the 
previous iteration, the subscript j_ indicates summation 
over all non-zero elements of *. ,(E.), and the sub-
i i j 
script k_ indicates that the computation is made for each 
channel number. For the first iteration ^-itE-) is set 
equal to one for all E.. 
J 
2. A trial fluence $.(E.) is calculated from the previous 
' J 
trial fluence *-_-i(E.) with 
i — i j 
E l R ( Nk ) ( 1 *D 
• - • • - k I M V ^
 x \ ( N k ) 
where the subscript k̂  indicates that the summation is 
computed for all non-zero elements of ̂ -(N^) and the 
subscript j_ indicates that the computation is made for 
each element in *._,(E.). The asterisk in RgP(Nk) 
J 
indicates that this distribution lis normalized over 
k, that is 
(3-3) 
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R E P <Nk> 
J 
R E . < N k > P 
I RE. ( N k )
P 
k J 
The superscripts £ and £ have the value of either 
1 or 2. Setting either or both equal to 2 increases 
the speed with which the iteration process converges. 
The next step is one in which the results of the 
iteration are evaluated. The residuals, S, are com-
puted by 
2 
I(R1(Nk) - R(Nk))' 
2 
(3-4) 
S = * < (3-5) 
I R(Nk)' 
k 
Thus S is a measure of how well the trial pulse height 
spectrum approximates the measured pulse height 
spectrum. In fact, the square root of S is the root-
mean-square of the difference between the trial 
and observed pulse height spectrum expressed as a 
fraction of the average value of the observed pulse 
height spectrum. If S is less than some pre-determined 
value, the iteration process is ended, and the final 
$.(E.) is taken to be an estimate of $(E), the fluence 
which actually caused the observed pulse height 
spectrum. This unfolding procedure is similar 
to one used to analyze electron swarm data (Mc72). 
65 
In this study S was chosen to be less than 0.0003. Hence 
the fractional-root-mean-square difference between the trial and ob-
served pulse height spectra was less than 1.8%. Examination of data 
taken previously showed that for a given exposure situation (i.e., x-ray 
beam site and location, detector position and orientation, generating 
potential, tube current, etc.), slightly different pulse height spectra 
would be observed. Statistical tests showed that the variation in a 
number of counts in a given channel was Poisson in nature. The standard 
deviation of the number of counts in a given channel, taken from a 
number of pulse height spectra acquired under similar conditions, was 
approximately equal to the square root of the mean of the number of 
counts. Most of the pulse height spectra which were unfolded in the 
course of this research had a maximum number of counts per channel 
between 50,000 and 100,000. Since these spectra approached zero on each 
end, there were a number of channels for which the expected standard 
deviation was on the order of 1% or greater. Thus requiring the 
residuals, S, to be smaller than 0.0003 would be requiring that the 
fractional root-mean-square difference between the trial and observed 
pulse height spectra be smaller than the expected error for a large number 
of channels in the observed spectrum. Nevertheless the selection of 0.0003 
as the maximum allowable value of the residuals is somewhat arbitrary. 
The spectral output of the x-ray machine was measured with the 
spherical Nal detector and with a Ge(Li) spectrometer. The Ge(Li) 
spectra were corrected for efficiency losses and were grouped into energy 
"bins", 2 keV wide. The Nal spectra were unfolded with the procedure 
defined above. The raw pulse height distributions, the unfolded Nal 
66 
spectra, and the corresponding Ge(Li) spectra for generating potentials of 
60 and 80 kVcp are presented in Figures 17 and 18. The spectra are 
normalized per unit fluence. Also the absorbed dose in reference man 
soft tissue was calculated for each unfolded spectrum with 
° - c ^ i r Ek*<Ek> (3-6) 
where uen/p is the mass energy absorption coefficient and c is the factor 
necessary to convert keV per gram to units of absorbed dose. 
The correspondence of the unfolded Nal spectra and the spectra 
measured with the Ge(Li) detector was taken as the best evidence that the 
unfolding procedures resulted in a measured spectrum which was a realistic 
estimate of the actual spectrum incident upon the spherical Nal detector. 
It should be noted that the unfolded Nal spectrum does not accurately 
represent the incident spectrum in a neighborhood around the barium 
K-edge and around the upper energy limit of the incident spectrum. 
According to Anderson this "rounding of the corners" was a natural conse-
quence of the poor resolution of the Nal spectrometer (An76). 
The inability of the spectrometer to resolve discontinuities 
similar to the barium edge is judged unimportant because it is felt that 
x-ray spectra present inside a phantom would not have such discontinuities 
There are only trace quantities of elements present in the human body 
(or in phantoms to represent the body) which have K-edges above 10 keV. 
Also any discontinuities in a spectrum incident on a phantom would be 
smoothed to some degree by the scattering processes within the phantom. 
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17. Comparison of Unfolded Nal(Ta) Spectrum with Spectrum 
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Figure 18. Comparison of Unfolded NaI(TO Spectrum with Spectrum 
Measured with a Ge(L1) Detector — 80 kVcp. 
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The inability of the unfolding processes to produce a spectrum 
which accurately represents the spectrum incident on the detector 
near the upper energy limit was judged to be a serious drawback to the 
use of this Nal detector. This drawback was dealt with in two ways 
in treating the data presented in subsequent chapters. First a 
numerical technique was used to compute the first derivative of a 
second order polynomial fit via least squares to a point in the un-
folded spectra and its two nearest neighbors on both sides (5 point 
fit) (Sa64). If this first derivative, computed for several points 
just below the energy of the generating potential, displays a relative 
minimum (i.e., largest negative slope) then the unfolded spectrum was 
adjusted. The adjustment was accomplished by replacing the data with 
energy greater than the point of minimum first derivative with the 
value obtained by linearly extrapolating from the point of minimum 
derivative with slope equal to that derivative. All negative values 
were truncated to zero. If the unaltered, unfolded spectrum failed to 
have a minimum of its first derivative in the neighborhood just below 
the generating potential, the unfolded spectrum was truncated to zero 
above the generating potential. Figure 19 shows the effect of 
extrapolation and truncation on a spectrum produced at 80 kVcp. 
Figure 19 presents two unfolded spectra along with the absorbed 
doses for each spectrum calculated with Equation (3-6) and the centroids 
for each spectrum (denoted by the short vertical tick mark). Both spec-
tra were unfolded from pulse height spectra collected with a generating 
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Figure 19. An Example of Truncation and Extrapolation. Vertical 
ticks indicate mean energy. Field size is in cm. D is 
the absorbed dose per unit current per unit time (mrad/mA-s) 
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approximately 1 keV with respect to the centroid calculated for the 
truncated spectrum. Also extrapolation reduced the calculated absorbed 
dose by 3% with respect to the absorbed dose calculated for the truncated 
spectrum. 
The truncation of the unfolded spectra above the generating 
potential was justified on the basis that no photons produced by an x-ray 
machine can have an energy greater than the kinetic energy of the electrons 
bombarding the x-ray tube target. The extrapolation procedure was based 
on the assumption that as a bremsstrahlun^ spectrum almost linearly 
approaches zero near its upper energy limit, so must a scattered 
bremsstrahlung spectrum. 
MR. ADAM Phantom 
In 1976, the ICRP published its report called Reference Man. This 
report contains a wide range of anatomical data for a model representative 
of an "average" adult human (ICRP75). Many of the data for this ICRP 
report were compiled over a period of years by the staff of the Medical 
Physics and Internal Dosimetry Section of the Health Physics Division of 
the Oak Ridge National Laboratory. While these data were being acquired, a 
model based on the same data was developed by the same section for use in 
Monte Carlo calculations (Fi67). In the model the three major body 
regions (head, trunk, and legs) and 23 major organs of interest were de-
scribed by segments of general quadratic surfaces such as spheres, ellip-
soids, elliptical cylinders, and flat plates. This calculational model was 
used to estimate the distribution of absorbed dose among the various 
organs and regions for sources of ionizing radiation both inside and outside 
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the model (Jo76, Po73, Po74a, Po74b, Sn73, Sn74). In 1969 the Medical 
Internal Radiation Dose Committee of the Society of Nuclear Medicine adapt-
ed this model for use in estimating the absorbed dose to patients ad-
ministered radionuclides internally for medical purposes (Sn69). In 
1974 the model was modified slightly to make it more suitable for calcula-
tions of radiation dose distributions from external sources of radiation. 
The revised model was used in calculations of dose distributions to assist 
the U.S. Bureau of Radiological Health in assessing medical diagnostic 
x-ray exposures (Po74b, Ro76a, Ro76b). 
In 1974 a phantom which was a physical mock-up of the mathematical 
model was built. Subsequently the phantom was used in several programs 
of measurements to provide experimental data for intercomparison with 
calculated data (Ga74, Me75, Sta75). When the mathematical model was 
modified, the phantom was modified also to reflect these changes (Me75). 
The MR. ADAM phantom (Mock-up of a Representative Analytical 
Description of an Adult Male), built for this study, is pictured in 
Figure 20. The phantom and the mathematical model which it represents 
have three body regions, head, trunk, and legs. Both phantom and model 
are comprised of subregions of different materials: skeletal, lung, and 
the rest (called "soft tissue"). The mathematical model, referred to as 
I the Snyder-Fisher phantom, specified the nature of each subregion by 
giving the chemical composition and density. These specifications are 
the ones upon which "reference man" is based. Note that the skeletal 
region is considered to be an homogeneous mixture of hard bone, bone 
marrow, connective tissue, and the amount of blood normally resident in 




Figure 20. The MR. ADAM Phantom. 
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The shells containing the body regions and skeletal and lung sub-
regions of the MR. ADAM phantom were constructed of lucite or polystyrene. 
The materials used to represent the elemental compositions specified in 
the Snyder-Fisher phantom were formulated using a computer program. Also 
the equivalence of the materials with respect to what they represent was 
assessed using the same program (St74). The criteria used for assessing 
the equivalence of the materials were to compare the partial mass 
attenuation coefficients and the density. Table 2 gives the elemental 
composition and density of the Snyder-Fisher phantom and the composition, 
chemical composition, and density of the substitute materials. Tables 3-5 
give the partial mass-attenuation coefficients of the substitute materials 
and their comparisons with the coefficients calculated for Snyder-Fisher 
phantom specifications. Note that in most cases the coefficients 
agree within +_ 1%. 
The MR. ADAM phantom was chosen for use in this study for three 
reasons. First, it resembles the Snyder-Fisher phantom, an accepted 
phantom of standard geometry. Second, since the phantom is mostly fluid-
filled, it allowed access to much of the interior with a probe the size 
of the spherical Nal spectrometer. Third, experimentally-determined data 
measured in the MR. ADAM phantom have the potential for being directly 
compared with corresponding data calculated in the Snyder-Fisher phantom. 
Table 2. Description of Snyder-Fisher phantom subregions and their MR. ADAM phantom equivalents 
Soft tissue Skeleton Lung 
Snyder-Fisher0 Equivalent Snyder-Fisher0 Equivalent0 Snyder-Fisher0 Equivalent 
Elemental composition, % 
H 10.474 11.26 7.036 6.47 10.208 9.78 
C 23.020 18.36 22.793 19.15 10.008 11.11 
N 2.339 3.865 3.94 2.802 
0 63.206 69.38 48.559 52.98 75.958 77.61 
Na 0.128 0.393 0.315 0.17 0.190 0.59 
Mg 0.016 0.111 0.18 0.008 
P 0.236 6.937 6.80 0.081 
S 0.221 0.169 0.01 0.230 
CI 0.141 0.607 0,139 0.270 0.91 
K 0.208 0.145 0.200 
Ca 9.914 10=30 0.007 
Fe 0.006 0.008 0.037 
Zn 0.005 0.010 0.002 
Density, g/cm 1.0 0.99 ± 0.01 1.5 1.50 ± 0.01 0.3 0.30 ± 0.01 
Composition given here is the same as given in MIRD Pamphlet No. 5 except that all elements with atomic number greater than 
zinc are considered zinc. 
feMade from 66% H20, 25% isopropyl alcohol, 8% sucrose, and 1% NaCl. 
cMade from bone flour, water sucrose, and salts. (Ga74). 
dMade from 73.5% H20, 25.0% cellulose (sponge), and 1.5% NaCl. 
Energy 
(keV) 
Table 3. Calculated partial mass attenuation coefficients for Snyder-Fisher 
composition and comparison*1 of equivalent material used in MR. ADAM 
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Table 4. Calculated partial mass attenuation coefficients for Snyder-Fisher 
composition and comparison*3 of equivalent material used in MR. ADAM 
phantom - skeleton 
Photoelectric Coherent Compton 
Energy Coefficient Comparison Coefficient Coi mparison Coefficient Comparison 
(keV) (cm2/g) (%) (cm2/g) (%) (cm2/g) (%) 
10 15.4 -1.2 0.327 1.5 0.143 -1.2 
15 4.62 -0.9 0.192 1.4 0.164 -0.9 
20 1.93 -0.8 0.126 1.4 0.174 -0.8 
30 0.554 -0.6 0.0671 1.4 0.181 -0.6 
40 0.267 -0.5 0.0416 1.4 0.179 -0.5 
50 0.113 -0.5 0.0282 1.4 0.176 -0.5 
60 0.0641 -0.5 0.0204 1.3 0.172 -0.5 
80 0.0261 -0.5 0.0120 1.3 0.162 -0.5 
100 0.0131 -0.5 7.90E-3 1.3 0.154 -0.5 
150 3.76E-3 -0.6 3.61E-3 1.3 0.138 -0.6 
200 1.57E-3 -0.6 2.04E-3 1.3 0.126 -0.6 
300 4.73E-4 -0.6 9.02E-4 1.3 0.109 -0.6 
400 2.06E-4 -0.6 5.02E-4 1.4 0.0981 -0.6 
500 1.10E-4 -0.6 3.18E-4 1.4 0.0905 -0.6 
600 6.66E-5 -0.5 2.19E-4 1.4 0.0848 -0.5 
800 3.08E-5 -0.5 1.22E-4 1.4 0.0768 -0.5 
1000 1.73E-5 -0.4 7.80E-5 1.5 0.0715 -0.4 
"Percent comparison of coefficients for equivalent material calculated as 
0*/p)eqUivalent ~ ^^Snyder-Fisher 
100 X 
- x j 
(Ai/p)Snyder-Fisher 
Table 5. Calculated partial mass attenuation coefficients for Snyder-Fisher 
composition and comparison" of equivalent material used in MR. ADAM 
phantom - lung 
Photoelectric Coherent Compton 
Energy Coefficient Comparison Coefficient Comparison Coefficient Comparison 





10 4.85 1.4 0.246 -0.8 
15 1.33 1.3 0.141 1.0 0.176 -0.7 
20 0.524 1.2 0.0918 1.0 0.186 -0.6 
30 0.140 1.0 0.0480 1.0 0.192 -0.5 
40 0.0549 0.8 0.0295 1.0 0.190 -0.5 
50 0.0266 0.7 0.0199 1.0 0.185 -0.5 
60 0.0147 0.6 0.0143 1.0 0.180 -0.5 
80 5.81E-3 0.5 8.43E-3 1.0 0.169 -0.4 
100 2.85E-3 0.4 5.52E-3 1.0 0.160 -0.4 
150 7.91E-4 0.2 2.51E-3 1.1 0.140 -0.4 
200 3.25E-4 0.1 1.42E-3 1.1 0.128 -0.4 
300 9.57E-5 0.1 6.29E-4 1.1 0.111 -0.4 
400 4.13E-5 0.2 3.51E-4 1.1 0.100 -0.4 
500 2.19E-5 0.3 2.23E-4 1.1 0.0926 -0.4 
600 1.32E-5 0.4 1.54E-4 1.1 0.0872 -0.4 
800 6.10E-6 0.5 8.60E-5 1.1 0.0798 -0.4 
1000 3.43E-6 0.6 5.49E-5 1.2 0.0751 -0.4 







RESULTS AND CONCLUSIONS 
Outline of Spectral Measurements 
The data, which comprise the body of the results of this project, 
were collected and processed as shown schematically in Figure 21. The 
spectrum measurements presented in this chapter were performed in a 
period of ten days. To ensure that long term drifts in the electronic 
equipment did not bias the data, the performance of the data collection 
system was checked daily. Pulse height spectra were collected for two 
sources ( C o and Am). If necessary, adjustments were made to the 
gain of the linear amplifier to ensure that the modal values of the 
pulse height distributions were observed in the proper channel. 
The Nal(Til) probe was positioned at seven different locations 
within or on the surface of the MR. ADAM phantom. At each probe location 
pulse height spectra were acquired for twenty-one combinations of seven 
beam configurations and three generating potentials (60, 80, 100 kVcp). 
In each case, the x-ray machine tube current was adjusted so that the 
multichannel analyzer was operating with a dead time of 10% or less. 
Tube currents used ranged from 20 mA to 0.1 yA. The analyzer was 
equipped with circuitry to correct for dead time, and this feature was 
used in acquiring all spectra. For each case, data were collected long 
I: 
enough to provide 50,000 to 100,000 counts per channel in the modal 
j 
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Figure 21. Data Acquisition and Processing Schematic 
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frequently, but occasionally counting times up to 500 seconds live time 
were necessary. Before each pulse height spectrum was punched on tape, 
all important parameters such as generating potential, tube current, 
detector location, etc. were punched on the tape manually to facilitate 
subsequent data processing. 
The seven probe locations were chosen to be at the center of or 
near seven regions of interest: the testes, the right ovary, the thyroid, 
the eyes, the heart, the fifth lumbar vertebra and the thoracic region of 
the spine. Testes, ovary, thyroid and eyes were chosen because of their 
radiological significance. The location near the heart was chosen to 
provide data for this organ and for other organs located nearby. The 
two locations in the spine were chosen to provide data for at least one 
of the skeletal structures containing red bone marrow. 
A rectilinear coordinate system whose origin is located at the 
center of the base of the torso section of the phantom was used to 
determine the coordinates of the probe locations and the organs. The 
coordinates of the centers of the organs chosen and the coordinates and 
reference numbers of the corresponding probe locations are given in 
Table 6. Figure 22 shows the x-axis and z-axis of the coordinate system. 
The y-axis is perpendicular to the x-z plane shown, and the positive 
y-direction is toward the posterior of the phantom such that the 
coordinate system is right-handed. 
The triangles in Figure 22, numbered 1 through 7 for cross-
reference with Table 6, show the location and approximate orientation of 
the probe within the phantom. The vertex of the acute angle of each 
triangle shows the position of the active volume of the detector. The 
Table 6. Summary of Probe Locations 
Reference 
Number 
Organ or Region Coordinates of Probe 
(X, Y, Z) 
tAi specified in Snyder-Fisher Phantom. 
*Not specifically defined in Snyder-Fisher Phantom. 
Coordinates of Center 
of Organ t 
(X, Y, Z) 
1 Testes -2.0, -7 .2, -3.0 - 1 . 3 , - 8 . 0 , - 2 . 3 
2 Right Ovary -6 .0 ,0 , 15.0 -6.0, 0, 15.0 
3 Fifth Lumbar Vertebra 0, center of spine, 23.0 * 
00 
4 Heart Region 0, 0, 44.0 1.0,-3.0,51.0 ro 
5 Thoracic Spine 0, center of spine, 47.0 * 
6 Thyroid Gland 0, -6.0, 72.5 0, -6.0, 72.5 
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base of each triangle indicates the direction of the photomultiplier tube 
housing part of the detector. Note that the triangles do not show the 
full length of the region occupied by the probe. (The probe was over 
20 cm long, half the width of the phantom.) The detector was oriented 
parallel to the x-z plane for the eye, heart, and two spine regions. In 
the right ovary location the probe was positioned with its base toward 
the posterior of the phantom (inclined approximately 30° to the x-z 
plane). In the testes location the probe was positioned with its base 
toward the anterior (inclined approximately 15° to the x-z plane). The 
probe was positioned at the thyroid location by placing it parallel to the 
y-z plane inclined toward the posterior approximately 60° from the z-axis. 
To facilitate positioning the probe, the configuration of the 
phantom was changed in some cases, and a number of methods were used to 
hold the probe. A device was built to hold the probe at the heart and 
right ovary locations. The device, built mostly of nylon and lucite, 
consisted of an x-y translator that was bolted to the top of the torso and 
a 1 cm square polyester rod that provided z-directi on movement. When this 
device was used, the head section of the phantom was not emplaced. The 
detector was held in the spine by means of two nylon collars that were 
fastened to the photomultiplier tube housing. In this case the head was 
not used also. The detector was positioned at the eye, thyroid and 
testes with a variety of small clamps and rods. The skull was removed 
when thyroid measurements were made. Entrance to the testes region was 
accomplished via a latex covered hole in the base of the male genitalia 
region. 
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In all cases care was taken to minimize the "shielding" of the 
Phantom or the probe with parts of the positioning apparatus. The sizes 
of the phantom and the detector prohibited placing the detector in a 
desired attitude directly at the center of the heart and the testes. 
The detector was not positioned at the center of the eye region because 
of slight discrepancies between the shape of the heads of the Snyder-
Fisher phantom and the MR. ADAM phantom. Laser beams, a plumb bob, and 
a meter stick were used to determine accurately the position of the 
detector within the phantom. It was estimated that the overall positioning 
accuracy was +0.3 cm. 
Beam sizes and locations simulating x-ray examinations of the 
chest, left shoulder, upper gastro-intestinal (upper G.I.), pelvic and 
two spinal regions were selected. Several factors were considered in 
choosing the particular radiological examinations to be simulated. It 
was desired to choose a set of exposure configurations which would be 
both representative of the most frequent medical x-ray examinations and 
yet not redundant. For example, the pelvic exam and an abdominal exam 
were selected, but a pyelogram, which might be centered slightly differ-
ently but in between the two, was not. Also examinations of the head 
and extremities were not chosen because of the phantom's over-simplified 
geometry in these regions. The abdominal and two spinal configurations 
were chosen to have the same beam center so that the effect of field 
size could be studied. 
Generally anatomical landmarks such as the xiphoid process, the 
bi-iliac crest, and the pubic symphysis are used in positioning x-ray 
beams with respect to a human patient. Since there was some uncertainty 
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in ascertaining the locations on the phantom that corresponded to the 
landmarks, there was some difficulty in selecting the beam configura-
tions. However, with the help of an x-ray technologist, the seven 
beam sizes and positions were defined. 
All examinations were simulated with the phantom standing erect. 
A simulated focal-spot-to-film distance of 120 cm was chosen because the 
collimator would not open wide enough to accommodate the largest beam 
size (36 x 44 cm) at the more conventional distance of 102 cm (40 
inches). For each simulated examination the collimator and the tube 
height were adjusted until the beam was positioned and sized appropriately 
at the plane that would be occupied by the film in a real x-ray examin-
ation. The outline of the beam where it entered the phantom was marked 
for subsequent use. 
The beam sizes and locations are pictured in Figures 22-28. Note 
that the shaded area shows the outline of the beam on the anterior of the 
phantom and that the dotted lines show the outline on the posterior. 
Figure 28 shows the configuration for a chest x-ray which had the beam 
; incident on the posterior of the phantom. 
i 
In addition to the 147 combinations of detector location, beam 
(Configuration, and generating potential described above, several other 
'[configurations were employed. Spectra were acquired at the testes with 
: the male genitalia region shielded with a 10 x 15 cm sheet of lead 
0.16 cm thick. For the shoulder exam spectra were acquired at the thyroid 
with the neck shielded with a similar sheet of lead covering the front 
i half of the neck region. The locations of the testes and thyroid shield 
are shown in Figure 26. Also for the shoulder exam, additional measure-
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Figure 23. Beam Location for Full Spine 10 x 44 cm Field (Center 
at x = 0, z = 22). 
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Figure 24. Beam Location for Abdominal 36 x 44 cm Field (Center at 
x = 0, z = 22). 
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Figure 25. Beam Location for Shoulder 36 x 44 cm Field (Center at 






Figure 26. Beam Location for Upper Gastro-Intestlnal (Upper G 
36 x 22 cm Field (Center at x = 0, z = 36). 
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Figure 27. Beam Location for Pelvic 44 x 36 cm Field (Center at 





Figure 28. Beam Location for Chest Posterior-Anterior 36 x 44 cm 
Field (Center at x = 0, z = 53). 
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ments were made at the eyes and thyroid with a beam size slightly smaller 
than otherwise employed. For the upper G.I., shoulder, and chest exams, 
measurements at the right ovary were made with the phantom shielded with 
an apron of 0.16 cm thick lead. When used, the apron was placed just 
below the edge of the beam and was large enough to completely cover the 
lower half of the torso. Further special measurements in and around the 
heart region were made for a number of 10 x 10 cm beams incident nearby. 
These special configurations will be explained in the next section. 
After the program of measurements outlined above was completed, 
the pulse height distributions were unfolded and graphed. The results 
were normalized per unit tube current and per unit time. (Tube current 
was expressed in milliamps in this text because of its traditional accept-
ance in the field of diagnostic radiology). As the data were processed 
the centroid and the normalized dose rate [calculated from the unfolded 
spectra with Equation (3-6)] were calculated., The centroid and dose 
rates for all exposure configurations are summarized in Tables 7-9. 
The unfolded spectra are presented graphically in Appendix A. 
Highlights of Results 
Protective Measures 
The effect of gonad shielding on the absorbed dose rate and the 
spectrum at the testes was investigated. As was explained previously, 
pairs of spectra were collected in identical manners except that in one 
of each pair a testes shield was used. The spectra and absorbed dose 
rates for the pelvic, abdominal and upper G.I. exams for 60 and 80 kVcp 
are given in Figures 29-31. The approximately 90% reduction in absorbed 
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60 kVcp 80 kVcp 100 kVcp 
Location D* Centroiclc D Centroid D Centroid 
Testes Lower Spine 10 X 10 
w/s 


















































































Chest 3 6 X 4 4 PA 1.03E-4 37 4 .24E-4 45 1.23E-3 51 
Right Ovary Lower Spine 10 X 10 1.20E-2 38 4 .57E-2 46 1.06E-1 52 
Full Spine 10 X 44 5.21E-2 37 2.08E-1 46 4 .56E-1 52 
Abdominal 36 X44 i t 3.48E-1 39 9.98E-1 48 2.29 55 




























Pelvic 44 X 36 t 1.50E-1 39 6.45E-1 48 1.45 56 














aw/s indicates that testes were shielded with a 10 X 15 cm piece of lead 0.16 cm thick. 
w/A indicates that an apron of lead 0.16 cm thick was used to cover the lower torso. The upper edge of the apron 
abutted the lower edge of the beam. 
f indicates that the detector was located in the primary beam. 
PA indicates that the beam was incident posterior-anterior. 
D is the absorbed dose rate per unit tube current. It has units of mrad/sec-mA. 
cThe centroid is the centroid of the fluence vs energy distribution. It has units of keV. 
d 4 .37E-4 means 4.37 X 1 0 - 4 . 
95 






60 kVcp 80 kVcp 100 kVcp 
Location Db Centroidc D Centroid D Centroid 
Heart Region Lower Spine 10 X 10 7.61E-4 41 3.11E-3 48 8.93E-3 54 
Full Spine 10 X 44 1.21E-2 37 9.31E-2 48 2.09E-1 55 
Abdominal 3 6 X 4 4 2.64E-2 37 1.91E-1 48 4 .54E-1 55 
Shoulder 3 6 X 4 4 3.54E-2 36 1.98E-1 47 4 .44E-1 53 
Upper G.I. 36 X 22 t 1.35E-1 37 8.04E-1 49 1.73 56 
Pelvic 44 X 36 2.33E-4 36 1.93E-3 47 5.08E-3 54 
Chest 3 6 X 4 4 PAf 9.71E-2 37 6.29E-1 49 1.53 56 
Thoracic Spine Lower Spine 10 X 10 3.14E-5 38 7.58E-4 49 2.55E-3 56 
Full Spine 10 X 44 1.27E-3 38 2.17E-3 51 6.45E-2 58 
Abdominal 36 X 44 3.00E-3 38 4.85E-2 50 1.34E-1 57 
Shoulder 36 X 44 9.12E-2 38 7.41E-2 50 2.10E-1 57 
Upper G.I. 36 X 22 1.35E-2 38 1.36E-1 51 3.90E-1 59 
Pelvic 44 X 36 3.05E-5 37 6.10E-4 49 2.02E-3 55 
Chest 3 6 X 4 4 PAf 2.39E-1 37 1.42 50 3.26 57 
Fifth Lumbar Lower Spine 10 X 10 t 1.13E-2 39 1.10E-1 52 2.82E-1 60 
Vertebra Full Spine 10 X 44 t 1.53E-2 38 1.64E-1 51 4.25E-1 58 
Abdominal 3 6 X 4 4 t 2.54E-2 38 2.71E-1 50 4 .48E-1 56 
Shoulder 3 6 X 4 4 1.02E-4 36 1.52E-3 47 4 .42E-3 53 
Upper G.I. 36 X 22 2.49E-3 37 3.40E-2 48 9.01E-2 54 
Pelvic 44 X 36 3.39E-3 38 4.73E-2 49 1.39E-1 55 
Chest 3 6 X 4 4 PA 1.66E-3 36 1.41E-2 47 3.56E-2 53 
aw/s indicates that testes were shielded with a 10 X 15 cm piece of lead 0.16 cm thick. 
t indicates that the detector was located in the primary beam. 
PA indicates that the beam was incident posterior-anterior. 
bD is the absorbed dose rate per unit tube current. It has units of mrad/sec-mA. 
cThe centroid is the centroid of the fluence vs energy distribution. It has units of keV. 
d7.61E-4 means 7.61 X 10"4. 
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60 kVcp 80 kVcp 100 kVcp 
Location D* Centroidc D Centroid D Centroid 
Thyroid Gland Lower Spine 10 X 10 1.65E-5 36 9.70E-5 46 2.34E-4 54 
Full Spine 10 X 44 1.37E-4 35 8.37E-4 45 1.90E-3 52 
Abdominal 36 X 44 5.07E-4 35 2.89E-3 45 6.60E-3 52 
Shoulder 36 X 44 t . 4.46E-1 36 2.00 48 3.79 57 
36 X 44 w / s d t 4 .56E-2 35 2.61E-1 46 5.61E-1 53 
28 X 44 Smaller 
beam 
3.18E-2 35 2.53E-1 44 5.10E-1 51 
Upper G.I. 36 X 22 5.34E-4 35 3.62E-3 45 8.56E-3 52 
Pelvic 44 X 36 1.68E-4 36 8.86E-4 46 1.88E-3 53 
Chest 36 X 44 PA 1.60E-2 37 1.61E-1 49 3.55E-1 55 
Eye Region Lower Spine 10 X 10 7.16E-5 32 2.48E-4 41 4.34E-4 48 
Full Spine 10 X 44 3.84E-4 32 1.21E-3 40 2.05E-3 46 
Abdominal 36 X 44 1.50E-3 32 4.28E-3 40 7.03E-3 47 
Shoulder 36 X 44 6.54E-2 33 1.76E-1 42 3.23E-1 49 
28 X 44 Smaller 
beam 
3.39E-2 33 1.04E-1 42 1.89E-1 49 
Upper G.I. 36 X 22 1.13E-3 32 3.25E-3 41 5.43E-3 47 
Pelvic 44 X 36 8.87E-4 32 2.55E-3 41 4 .43E-3 47 
Chest 36 X 44 PA 5.81E-4 36 8.12E-3 48 2.04E-2 55 
2w/s indicates that testes were shielded with a 10 X 15 cm piece of lead 0.16 cm thick. 
f indicates that the detector was located in the primary beam. 
PA indicates that the beam was incident posterior-anterior. 
D is the absorbed dose rate per unit tube current. It has units of inrad/sec-mA. 
"The centroid is the centroid of the fluence vs energy distribution. It has units of keV. 
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Figure 29. Effect of Gonad Shield on the Spectrum at the Testes --
Pelvic Exam (Testes in the Beam). Vertical ticks indicate 
mean energy. Field size 1s in cm. D is the absorbed dose 
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Figure 30. Effect of Gonad Shield on the Spectrum at the Testes — 
Abdominal Exam (Testes Near the Beam). Vertical ticks 
indicate mean energy. Field size 1s 1n cm. D 1s the 
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Figure 31. Effect of Gonad Shield on the Spectrum at the Testes --
Upper G.I. Exam (Testes Far from the Beam). Vertical 
ticks indicate mean energy. Field size is in cm. D is 
the absorbed dose per unit current per unit time (mrad/mA-s) 
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dose caused by the shielding in the pelvic exam (in which the testes 
were in the direct beam) was not surprising. However for the abdominal 
exam, in which the testes were just out of the beam, and for the upper 
G.I., in which the testes were farther from the beam, shielding reduced 
the absorbed dose rates also. These reductions were surprising because 
they indicate that, for the cases in which the testes are out of the beam, 
a significant component of the absorbed dose comes from radiation 
scattered from the collimator. The testes data in Table 7 and in 
Appendix A show the effect of shielding for all configurations in which a 
shield was used. 
The effect of collimator scattering has been reported previously by 
Trout and Kelley (Tr65). Because of the manner in which their data were 
presented, direct comparison between their results and the collimator 
scatter measured in this study was not feasible. 
To ensure that collimator or tube head leaks did not contribute 
to the spectra measured at the testes, the collimator was enshrouded 
with additional lead shielding, and the entire collimator and tube 
housing were checked for radiation leaks.. The collimator, with blades 
closed, and tube housing were wrapped with x-ray film and, also, were 
surveyed by hand with a Geiger counter. No evidence of radiation above 
background was found. 
Shielding also reduced the absorbed dose at the right ovary. 
For the cases in which the ovaries were not in the direct beam (upper 
G.I., shoulder, and chest exams), spectra were collected with and without 
an apron covering the lower part of the torso. The apron, comprised of 
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0.16 cm thick lead, was placed so that it was just below the lower edge 
of the beam in all cases. The results are presented graphically in 
Figures 32-37. Note that the fraction that: the absorbed dose is re-
duced by shielding is largest when the beam is farthest from the right 
ovary (shoulder exam), but that the amount of the absorbed dose reduction 
is largest when the beam is closest (upper G.I.). 
The effect of shielding on the spectrum and absorbed dose at the 
thyroid from a shoulder exam was studied. Spectra were collected with 
and without a shield covering the front half of the neck (lower part of 
head) of the phantom. Also collected was a spectrum for which the beam 
was 8 cm narrower (4 cm on each side). Comparisons of the spectra and 
absorbed dose rates for these three configurations are given in Figures 
38-40. The label "SSFS" stands for "slightly smaller field sizes" and 
indicates a 28 x 44 cm beam rather than a 36 x 44 cm beam. Note that 
shielding the thyroid reduced teh absorbed dose rate was reduced even 
further when a smaller field size was used instead of a neck shield. 
The sparing effect of using a smaller shoulder beam size was studied 
for the case of the eyes. A comparison of the absorbed dose and spectrum 
for a 36 x 44 cm beam and a 28 x 44 cm beam can be made by scrutinizing 
Figures 99 and 100 in Appendix A. In this case the sparing is on the 
order of a factor of two. 
Effect of Depth of Penetration, Scattering Distance and Beam Size 
A special series of measurements was conducted to observe changes in 
the shape of an x-ray spectrum as a function of depth of penetration 
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Figure 32. Effect of Shielding with an Apron on the Spectrum at the 
Right Ovary — Upper G.I. Exam -- 60 and 80 kVcp. Vertical 
ticks indicate mean energy. Field size 1s in cm. D is 
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ENERGY (KEV) 
Effect of Shielding with an Apron on the Spectrum at the 
Right Ovary -- Upper G.I. Exam — 100 kVcp. Vertical ticks 
Indicate mean energy. Field size 1s 1n cm. D 1s the 
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Figure 34. Effect of Shielding with an Apron on the Spectrum at the 
Right Ovary ~ Chest PA Exam — 60 and 80 kVcp. Vertical 
ticks indicate mean energy. Field size 1s 1n cm. D 1s 
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ENERGY (KEV) 
Effect of Shielding with an Apron on the Spectrum at the 
Right Ovary — Chest PA Exam — 100 kVcp. Vertical ticks 
Indicate mean energy. Field size 1s 1n cm. D 1s the 
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Figure 36. Effect of Shielding with an Apron on the Spectrum at the 
Right Ovary — Shoulder Exam — 60 and 80 kVcp. Vertical 
ticks Indicate mean energy. Field size is 1n cm. D 1s 
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Effect of Shielding with an Apron on the Spectrum at 
the Right Ovary -- Shoulder Exam — 100 kVcp. Vertical 
ticks Indicate mean energy. Field size 1s 1n cm. D is 
the absorbed dose per unit current per unit time (mrad/mA-s) 
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Figure 38. Effect of Shielding and Field Size on the Spectrum at the 
Thyroid — Shoulder Exam — 60 kVcp. Vertical ticks indicate 
mean energy. Field size is in cm. D is the absorbed dose 
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Figure 39. Effect of Shielding and Field Size on the Spectrum at the 
Thyroid ~ Shoulder Exam -- 80 kVcp. Vertical ticks indicate 
mean energy. Field size 1s 1n cm. D 1s the absorbed dose 
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Figure 40. Effect of Shielding and Field Size on the Spectrum at the 
Thyroid -- Shoulder Exam — TOO kVcp. Vertical ticks Indicate 
mean energy. Field size is In cm. D 1s the absorbed dose 
per unit current per unit time (mrad/mA-s). 
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location, and a 10 x 10 cm beam was centered directly over the active 
volume of the detector. Spectra were acquired for the detector in the 
heart region location ( x = o , y = o , z = 44) and for four other positions 
each 1 cm closer to the anterior of the phantom (x = o, z = 44, y = -1, 
-2, -3, -4). The results for each generating potential are presented in 
Figures 41-43. The hardening of the spectrum with depth can be ob-
served by noting the shift of the centroid. The average energy increased 
1 keV for the 60 kVcp spectra and 2 keV for the 80 and 100 kVcp spectra 
over the range of 5 cm that was studied. 
Another series of measurements was conducted to determine the effect 
of scattering on the spectral distribution. The detector was positioned 
in the heart region location, and spectra were acquired for six, 10 x 10 
cm beams incident on the anterior of the phantom. The six beams were 
centered at x = o and z = 39, 34, 29, 24, 19, 14, respectively. Thus, 
the projections in the x - z plane of the center of the detector and the 
center of the x-ray fields were separated by 6, 11, 16, 21, 26, and 31 
cm. The spectra of scattered radiation for 80 and 100 kVcp cases are 
presented in Figures 44-47. The detector-field-separation is abbreviated 
DFS and has units of centimeters. It was observed for both cases that 
the centroid and the shape of the unfolded spectra varied little over the 
range of detector-field-separation used. 
It was desired to assess the effect of beam size on the spectrum and 
absorbed dose rate for a combination of beam locations and detector 
locations. Since the simulated lower spine, full spine, and abdominal 
exams had the same beam center, data obtained for these cases was 
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Figure 41. Spectrum as a Function of Depth -- 60 kVcp. Vertical ticks 
Indicate mean energy. Field size 1s 1n cm. 0 1s the absorbed 
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Figure 42. Spectrum as a Function of Depth — 80 kVcp. Vertical ticks 
indicate mean energy. Field Size is in cm. D is the absorbed 
dose per unit current per unit time (mrad/mA-s). 
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Figure 43. Spectrum as a Function of Depth ~ 100 kVcp. Vertical ticks 
Indicate mean energy. Field size 1s 1n cm. D 1s the absorbed 
dose per unit current per unit time (mrad/mA-s). 
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Figure 44. Scattered Spectrum as a Function of Detector-Fleld-Separatlon 
(DFS In Units of Centimeters) — 80 kVcp. Vertical ticks 
Indicate mean energy. Field size 1s 1n cm. D 1s the absorbed 
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Figure 45. Scattered Spectrum as a Function of Detector-Field-Separation 
(DFS 1n Units of Centimeters) — 80 kVcp. Vertical ticks 
Indicate mean energy. Field size 1s 1n cm. D 1s the absorbed 
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Figure 46. Scattered Spectrum as a Function of Detector-Field-Separation 
(DFS in Units of Centimeters) — 100 kVcp. Vertical ticks 
indicate mean energy. Field size is in cm. D is the absorbed 
dose per unit current per unit time (mrad/mA-s). 
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Figure 47. Scattered Spectrum as a Function of Detector-Field-Separation 
(DFS in Units of Centimeters) — 100 kVcp. Vertical ticks 
indicate mean energy. Field size is in cm. D is the absorbed 
dose per unit current per unit time (mrad/mA-s), 
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dose rates for these three beam configurations are presented in 
Appendix B for all combinations of generating potential and detector 
location (heart region omitted). Except for the cases in which changing 
the field size affected whether or not the detector was in the direct 
beam (right ovary or heart locations), the shapes of the spectra varied 
little as a function of beam size. On the other hand, the absorbed dose 
rate for any particular combination of generating potential and detector 
location varied greatly. A quick analysis showed that this variation was 
not a simple one. In particular, the absorbed dose rate at a particular 
organ did not vary as a linear function of beam area. 
Spectra Inside the Spine 
The spectra measured with the detector in the spine locations were 
different in three ways from those measured in soft-tissue regions. The 
"in-bone" spectra had average energies that were generally higher than 
those in soft-tissue (see Table 8). The heart region data and thoracic 
spine data were selected for comparison since these detector configura-
tions had similar attitudes and locations. The 60, 80, and 100 kVcp 
spectra for the thoracic spine were harder than the corresponding heart 
region spectra by about 1, 2, and 3 keV, respectively. 
Second, the shape of the in-bone spectra was different. In general, 
the modal energy for any spectrum was below the average energy for that 
spectrum. However, the difference between the mean energy and the modal 
energy was usually smaller for the in-bone spectra than for the soft-
tissue spectra. See Figures 61-67 and 89-95 in Appendix A. Third, the 
magnitude (modal energy height, total fluence, or absorbed dose) was a 
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more sensitive function of generating potential for spectra acquired in 
the spine than for spectra acquired in other regions. Note that the 60 
kVcp spectra for spine locations generally were graphed with a scaling 
factor of 10 in order to make them comparable with their respective 80 
and 100 kVcp spectra. For soft-tissue region spectra, such scaling often 
was not necessary. 
Error Analysis 
The major sources of error in this study were judged to have arisen 
from the non-uniformity of the response of the detector as a function of 
angle of incidence, the inaccuracies in the response functions used to 
unfold the pulse height spectra, the low resolution of the spectrometry 
system in general, and the dissimilarity between the spectral output of 
the x-ray machine and spectra more representative of diagnostic radiology. 
It is important that the effects and limitations imposed by these sources 
of error be kept in mind when the data gathered in this study are inter-
preted. 
As is presented in Figure 12, the response of the detector was a 
function of both energy and declination of a beam of incident x-rays. 
Since the angular distribution of an x-ray field within the phantom was 
unknown in general, it was not possible to correct for this non-uniform-
ity of response. As was discussed previously, the detector was oriented 
to minimize such uncertainty. If it is presumed that the majority of 
the photons striking the detector were incident with a declination 
between +_ 45°, the uncertainty in energy would be limited. For 50 keV 
photons incident within the described solid angel, the variation in the 
mean of the observed pulse height distribution would be approximately 5%. 
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Therefore, it is judged that the uncertainty in the centroids of the 
unfolded spectra (all of which are near 50 keV) is ±2 keV. 
The response functions used to unfold the pulse height spectra 
were formulated by combining data from Monte Carlo calculations and 
measured characteristics of the detector. The Monte Carlo calcula-
tions were performed for an exactly spherical volume of Nal, whereas 
the detector itself was slightly oblate. Obviously, the probability 
of Compton scattered photons and fluorescent x rays escaping the de-
tector is dependent on the shape of the detector. Other inaccuracies 
in the response functions were deduced by examination of the unfolded 
spectra. All spectra suffered from the "rounding of the corners" 
caused by the inherent poor resolution of the system. Also each 
unfolded spectrum had some inaccuracy near 32 keV, the iodine K-edge. 
Initial calibration of the detector showed a change in linearity at 
this energy. Apparently this change was not represented completely 
properly in the response functions because the unfolded spectra dis-
played an artificial "fine structure" at 32 keV. It was not known how 
to assess the overall effect of the inaccuracies described above. 
It is suggested that the performance of the unfolding procedure be 
gauged by the examples of the unfolding of known spectra given pre-
viously (Figures 17 and 18). 
In order to have an x-ray machine with the wide dynamic range 
and other characteristics essential to this project, it was 
necessary to accept output spectra that were significantly different 
than those typical of medical diagnostic: radiology. The x-ray machine's 
output spectra were particularly dissimilar in the region near 37 keV, 
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the barium K-edge (see Figure 10). Measured spectra which heavily depend 
on the shape of the output spectra in this region should be viewed as 
approximations of those spectra which would be present in actual diagnos-
tic examinations. For example, the spectrum at the testes due to a pel-
vic exam should be considered very approximate since the beam of x-rays; 
has penetrated only a few centimeters of tissue. However, as a beam 
continues to penetrate the phantom, the photons with energy near 37 keV 
would be attenuated and would be replaced by degraded photons which ori-
ginally had a higher energy. Thus spectra at locations deep in the phan-
tom or outside the primary beam would not be as strongly influenced by 
the low energy components of the output spectra and should be more repre-
sentative of those that are present in an actual diagnostic exam. How 
well the spectra of a particular x-ray machine resembles the spectra of 
the x-ray machine used in this study may influence the applicability of 
the data presented in this study. 
Other sources of error include the statistical errors inherent in 
x-ray detection, short-term and long-term fluctuations in the electronic 
equipment including the high voltage stabilization circuitry of the 
x-ray machine, the inaccuracies in the phantom and its tissue-equivalent 
materials, and the positioning of the probe and the x-ray beams. It is 
estimated that the probe was positioned within the phantom with an 
accuracy of +_ 0.3 cm and that the beam was aligned with a similar 
uncertainty. These uncertainties are well within the variation that 
would be typical of actual diagnostic examinations. The uncertainties 
due to electronic equipment and the phantom are judged to be of much 
lesser significance than the errors discussed in the preceding paragraphs. 
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A set of ionization chamber measurements were made to provide data 
with which to estimate the accuracy of the absorbed dose rates calcula-
ted from the measured spectra. For reasons of convenience and feasi-
bility, measurements were made in the testes regions with the 3 cm 
probe of the Radocon III. The measured absorbed dose rates at the 
testes for three beam configurations and two generating potentials are 
presented in Table 10 along with the absorbed dose rates determined from 
the corresponding spectral mesurements,, The absorbed dose rates deter-
mined from the spectrum measurements vary from 16% lower to 6% higher 
than the absorbed dose rates measured with the ionization chamber. How-
ever, the difference between the two types of measurements did not 
appear to be random. Excepting one case, the absorbed dose rates deter-
mined from the spectrum measurements were smaller than the results 
indicated by the ionization chamber. Two explanations for this differ-
ence are given. The absorbed dose determined with the spectrometer 
should be lower than the actual absorbed dose because the truncation 
and extrapolation processes used to adjust the unfolded spectrum de-
crease the total fluence slightly. Second, the size of the ionization 
chamber influenced its response compared with the spectrometer. The 
radius of the ionization chamber was 1.3 mm larger than the radius of 
the beryllium cap of the spectrometer. Hence, the ionization chamber 
displaced more tissue fluid than the spectrometer, and, under similar 
conditions, more x rays would reach the ionization chamber than would 
reach the spectrometer because of absence of the displaced tissue fluid. 
Nevertheless, the purpose of the ionization chamber measurements was to 
check the general validity of the method of determining the absorbed 
TABLE 10. Comparison of Ionization Chamber Measurements with the Absorbed Dose Rate 













80 Full Spine 2.35 x 10"2 + 7%a 1.97 x 10"2 -16% 
Abdominal 5.21 x 10"2 + 7% 4.35 x 10"2 -16% 
Pelvic 2.39 + 7% 2.02 -16% 
100 Full Spine 0.121 + 7% 0.117 - 3% 
Abdomi nal 0.283 + 7% 0.299 6% 
Pelvic 8.50 + 7% 7.70 - 9% 
Uncertainty includes + 4% for angular response of probe and + 3% for calibration uncertainty. 
It does not include any uncertainty due to geometrical considerations. 
Spectrometer Measurement - Ionization Chamber Mpa<;nrpmpnt 
Ionization Chamber Measurement 
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dose from the measured spectra. In this respect, the agreement between 
the absorbed doses was adequate. 
Comparison with BRH Calculations 
As was discussed in Chapter III, the U. S. Bureau of Radiological 
Health published the results of a Monte Carlo study of absorbed doses to 
selected organs for common projections in diagnostic radiology (Ro76b). 
In this study a divergent beam of x-rays was simulated with a combination 
of 4 x 4 cm parallel beams. Further instead of making calculations for 
continuous spectra typical of diagnostic radiology, the absorbed doses 
were calculated as a linear combination of 5 monoenergetic beams. The 
calculations were made using the mathematical model on which the MR. 
ADAM phantom is based. Absorbed doses were calculated for the testes, 
ovaries, thyroid, active bone marrow region, and uterus. Typical expo-
sure configurations were assumed and the results are presented as a 
function of half-value-layer (HVL). 
The results for the testes, ovaries, and thyroid for the chest PA, 
pelvic, and abdominal examinations as measured in this study are com-
pared in Table 11 with the results of the BRH calculations most similar. 
In the calculated chest PA case, the focal-spot-to-film distance employed 
was 183 cm; in all measurements a distance of 120 cm was used. The hip 
exam in the BRH calculations had a configuration best resembling the 
pelvic exam simulated in the measurements. The abdominal exams in both 
studies were essentially the same. Due to statistical uncertainties, 
the calculated absorbed dose in some cases was presented as a small but 
unestimated number (i.e., < 0.01 mrad). 
TABLE 11. Comparison of Measured Absorbed Dose with BRH Calculations 
Beam Type 
Organ of Interest 
Generating Potential (kVcp) 
HVL (mmAl) 




























Measured Absorbed Dosea 0.033 0.066 0.15 0.15 0.89 1.9 5.2 25 43 
Percent Difference0 * * * -18% -19% -21% -65% -22% -10% 











Measured Absorbed Dosea 652 667 939 48 101 177 0.054 0.14 0.23 
Percent Difference0 - 10% - 25% - 4% -61% - 51% - 35% * * * 









Measured Absorbed Doseb 14 21 36 112 ICC *\CC ibu JD3 0.16 0.45 0.81 
Percent Difference0 40% 17% 38% - 13% - 29% - 25% * * * 
•Undetermined. 
aAverage absorbed dose (mrad) for exposure at surface of the phantom of 1000 mR as calculated (Ro76). 
Absorbed dose determined from spectra measurements made at the center of the organ of interest. Absorbed dose is 
normalized to 1000 mR incident exposure. 
°measured-calculated 
calculated 
Absorbed dose for both hips exposure configuration. 
(Coefficient of variation for 4 x 4 cm beam closest to the organ of interest, coefficient of variation for 4 x 4 
beam at center of field). NC means no calculated contribution for this 4 x 4 beam. 
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Since the BRH publication presented no estimated error with each 
calculation, Table 11 contains a pair of numbers called reference un-
certainties. These numbers were abstracted from the results of the 
monoenergetic calculations (Ro76a). They are the coefficients of 
variation for two of the 55 keV 4 x 4 cm beams used in the BRH study. 
the first of the pair is the coefficient of variation for the 4 x 4 cm 
(contained in the projection) which passes through or comes closest to 
the organ of interest. The second of the pair is the coefficient of 
variation for the 4 x 4 cm at the center of the projection. The label 
"NC" indicates that the respective 4 x 4 cm beam did not contribute to 
the absorbed dose at the organ of interest, and, therefore, the 
coefficient of variation is undetermined. The reference uncertainties 
presented have no direct relation to statistical uncertainty in the 
result of the Monte Carlo study. However, since the calculated absorbed 
dose estimates were based on a linear combination of the results of a 
set of 4 x 4 cm beams at various monoenergies, the reference uncertain-
ties may give the reader a feel for the accuracy of the calculated results. 
There are several factors to consider when comparing the results of 
the two studies. The scheme used in the BRH calculations does not in-
clude any collimator scatter. This scattering explains why the two 
studies do not agree well when the organ of interest is far from the 
beam. Second, the absorbed dose to an organ was calculated as the 
absorbed dose averaged over the entire organ. In the experiments, the 
absorbed dose was measured at the center of an organ. Third, the 
necessary simplifying assumptions in the BRH calculations were many. 
Parallel beams replaced a divergent beam, the Monte Carlo radiation 
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transport methodology did not include coherent scattering, and entire 
diagnostic x-ray spectra were simulated by five monoenergetic beams. 
Finally the measured spectra were acquired with configurations (and 
spectra) which did not always resemble the conditions simulated by the 
BRH. That the results of two, widely differing, complex studies agreed 
as well as they do is surprising (and, to this author, pleasing). 
CHAPTER V 
FINAL SUMMARY 
The objectives of this study were the development of a spectrometry 
system suitable for in-phantom research, demonstration of the feasibility 
of in-phantom measurements of spectra, and determination of several dosi-
metric parameters within an anthropomorphic phantom exposed to x rays in 
a manner simulating medical diagnostic radiological examinations. It is 
felt that these objectives were met in general. Further, data relevant 
to the understanding of the transport of radiation within the human body 
and to the reduction of absorbed dose to patients undergoing x-ray exam-
inations were acquired. 
In addition to the design and development of the spectrometer, 
there were a few other technological problems met and overcome in the 
course of this study. The equipment needed to acquire and process the 
spectral data was not insignificant. Besides the multichannel analyzer, 
the use of a large and sophisticated computer system was essential. 
Second, even though a sodium iodide scintillation spectrometer can be 
operated at count rates higher than can most other spectrometers, the 
x-ray machine, especially developed for low current operation, was 
necessary. Without an x-ray source having a wide dynamic range (4.5 
orders of magnitude), this project could not have been performed. 
These two factors, extensive data handling capability and an x-ray 
machine with extended tube current range, limit the widespread applica-
bility of the spectrometry system developed. 
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There were three notable shortcomings of this project. As was 
discussed previously, the spectral output of the x-ray machine used was 
not the best simulation of diagnostic x-ray spectra. The use of a 
x-ray tube with a low barium content would have helped significantly. 
Due to budgetary and time constraints, procuring such a tube was not 
possible for this project. Second,despite the special design and con-
struction, the Nal detector used in the project did not have a completely 
uniform angular response. It seems that a better spectrometer could be 
designed by optimizing the light collection parts of the detector. It is 
suggested that the Nal sphere be completely imbedded in a larger polyvinyl 
toluene light pipe to provide more uniform light collection. Finally, 
the poor resolution of the detector was a major drawback. Building a 
small, submersible spectrometer with nearly uniform angular response, 
good resolution, and the capability to operate at high count rates may 
not be feasible with today's technology. 
The absorbed dose rates, determined from the measured fluence 
distributions, compared reasonably well with the few ionization chamber 
measurements and with the results of Monte Carlo calculations. The +15% 
agreement with ionization chamber measurements is close to the accuracy 
that is expected of many dosimetric techniques excepting those conducted 
under ideal conditions. The agreement with the results of the BRH 
Monte Carlo calculations does not appear good prima facie. However, there 
are several factors that make this comparison seem much better. The 
beam configuration, spectrum, and location of measurements did not 
exactly correspond to the respective quantities in the BRH calculations. 
Also the BRH estimations of absorbed dose were based on Monte Carlo 
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calculations, some of which had large statistical uncertainty. Further 
the measurements conducted in this study have a nontrivial, estimated, 
experimental error. 
The data acquired in this study may be of use to a variety of re-
searchers. However, potential users are cautioned against indiscrimin-
ately applying the results of this study before considering the suita-
bility of the MR. ADAM phantom and the degree to which the spectra used in 
this study simulate the spectra in the situation being studied. The MR. 
ADAM phantom has several regions of poor simulation including the head, 
the upper chest area, and the arm regions. Anyone specifically interest-
ed in these regions may find the MR. ADAM phantom and the results of this 
study unsuitable. Also, the results of this study may not be suitable 
to the study of a particular patient. Obviously, there is no patient 
quite like MR. ADAM, and the dissimilarity between this phantom and a 
particular patient will have to be evaluated in each case. The spectra 
of the x-ray machine used in this study only approximate spectra typical 
of diagnostic radiology. Further, depending on type of rectification, 
actual inherent filtration, and other factors, any particular x-ray 
machine may produce x rays with a spectral distribution and other 
characteristics that differ from "typical". It is suggested that at 
least the half value layer of the actual x-ray machine being studied be 
compared with that of the x-ray machine used in this study. Of course, 
direct determination of the output spectra of an x-ray machine would 
be the test indication of the similarity and differences between its 
spectra and the ones used in this study. However, since direct 
determination of the spectra of an x-ray machine by means of a high 
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resolution spectrometer is often difficult and expensive, determination 
of half value layer may be the only practical means of comparison. If 
the half value layers of the x-ray beams being considered are similar 
to the ones in this study, correction for exposure rate differences be-
tween the x-ray machines should lead to valid applications of the data 
presented in this text. 
Within the limits imposed by the accuracy of the simulations, the 
resolution of the detector, and the other experimental errors, the data 
acquired in this study revealed some interesting information concerning 
the transport of diagnostic x-rays in the human body. By far, the most 
important factor affecting spectral shape within the phantom was the 
generating potential. The second most important factor was the medium in 
which the spectrum was measured. The spectra measured in the spine had a 
higher average energy than those measured in soft-tissue. Depth of 
penetration into the phantom affected spectral shape. Over the range of 
depths for which spectra were acquired in the direct beam, the average 
energy of the measured spectra increased. However, the increase was not 
dramatic. At 100 kVcp generating potential with a 10 x 10 cm beam 
centered on the detector, the average energy of the measured spectrum 
increased from 54 keV to 56 keV as the detector was moved from y = 4 
to y = 0 (a change of 4 cm). However, the shape of the spectrum 
scattered from a 10 x 10 cm beam as a function of distance between the 
beam center and center of the detector did not change significantly over 
a distance of 31 cm. 
Data from the exposure configurations in which shielding was used 
demonstrated two effects relevant to the reduction of absorbed dose to 
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radiosensitive regions in patients undergoing x-ray examinations. 
The first effect is that of collimator scatter. Comparing the data 
acquired under configurations that were identical in all manners except 
shielding showed that in many cases, the effect of the shielding was 
significant. For regions of interest outside the useful beam, the 
radiation scattered from the collimator was of comparable size to the 
radiation scattered from the useful beam within the phantom. It seems 
that the amount of radiation scattered would depend on the design of the 
collimator. Since a therapy-type collimator was used in this study, it 
is not recommended that the data acquired be applied directly to consider-
ation of this effect. However, it is hoped that the trends in the data 
concerning collimator scatter might create some interest in this area. 
Additional experimentation would better define the nature of the colli-
mator scatter, and subsequent calculational investigations might produce 
a design for collimators optimized to reduce scatter. In addition to 
reduction of absorbed dose to patients, reduction of collimator scatter 
would improve the quality of radiographs. 
The second effect, relating to the reduction of absorbed dose, is 
merely a different view of the collimator scattering. Since collimator 
scattering was demonstrated to be significant, shielding body areas out-
side the useful beam would reduce the absorbed dose to radiosensitive 
areas such as blood-forming organs, thyroid, lens of the eyes, and 
reproductive organs. Data acquired in this study indicated that 
although the amount of absorbed dose reduction caused by shielding was 
often small, the fractional dose reduction was always significant. 
134 
Annually, millions of people in this country alone undergo 
x-ray examinations. When one considers that all absorbed dose to regions 
outside the useful beam is "wasted" and has the potential for doing only 
harm, using all reasonable methods to minimize absorbed dose to such 
regions in the millions of patients seems only reasonable. The results 
of this study indicate that shielding all body areas outside the area to 
be examined would be an easy way to help keep the risk from medical 
diagnostic x-rays "as low as practicable." 
APPENDIX A 
MEASURED SPECTRA 
Presented in this Appendix are the unfolded spectra for 147 
combinations of detector location, generating potential, and beam config-
uration. A summary of beam configurations and detector locations is 
given in Figures 22-28. In addition, the spectra acquired with the 
testes region shielded with 0.16 cm of lead are presented immediately 
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Figure 48. Spectrum at the Testes without Shield for Lower Spine. Ver-
tical ticks indicate mean energy. Field size is in cm. D 
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Figure 49. Spectrum at the Testes with Shield for Lower Spine Exam. 
Vertical ticks indicate mean energy. Field size is in cm, 
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Figure 50. Spectrum at the Testes without Shield for Full Spine Exam, 
Vertical ticks Indicate mean energy. Field size is 1n cm. 
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Figure 51. Spectrum at the Testes with Shield for Full Spine Exam. 
Vertical ticks indicate mean energy. Field size is in cm, 










DETECTOR LOCATION - TESTES N/0 SHIELD 
uoo_ 
- 8 0 0 _ 







— Ql 1 
1 
m e r e 
i 
1 
n n k \ / r p — 
H L L u n o L O r-1 DU r W L r 
36 X 44 • L, D=4.35E-02 
ABDOMINAL ! ! 
_ r ' L •j 80 KVCP _ 
D=1-36E-01 
L, 
u ' 1 0 Q K V C p 
L, D=2.99E-01 ~~ 
r' i 









— 1 r^ 
! i h 
i 
i L . — 
i 





h L . 
~i i 
• i 
"-1 L . — 
• 1 




h L ' 
i - . 
r^r \ ^ K -
L, H t*= r 1 1 n 1 1h 1 I 
20 30 40 50 60 70 
ENERGY (KEV) 
80 90 100 
Spectrum at the Testes without Shield for Abdominal Exam. 
Vertical ticks indicate mean energy. Field size is in cm. 





DETECTOR LOCATION - TESTES N/ SHIELD 
1-60 RLL CASES 








- 80 KVCP 
D=9.71E-02 























10 40 50 60 70 
ENERGY (KEV) 
80 90 100 
Figure 53. Spectrum at the Testes with Shield for Abdominal Exam. 
Vertical ticks indicate mean energy. Field size is in cm. 
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Figure 54. Spectrum at the Testes without Shield for Shoulder Exam. 
Vertical ticks indicate mean energy. Field size is in cm, 
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Figure 55. Spectrum at the Testes with Shield for Shoulder Exam. 
Vertical ticks indicate mean energy. Field size is in cm, 
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Figure 56. Spectrum at the Testes without Shield for Upper 6.1. Exam, 
Vertical ticks indicate mean energy. Field size is 1n cm, 
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Figure 57. Spectrum at the Testes with Shield for Upper G.I. Exam. 
Vertical ticks indicate mean energy. Field size is in cm, 
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Figure 58. Spectrum at the Testes without Shield for Pelvic Exam. 
Vertical ticks Indicate mean energy. Field size 1s 1n cm, 
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Figure 59. Spectrum at the Testes with Shield for Pelvic Exam. 
Vertical ticks indicate mean energy. Field size is in cm. 
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Figure 60. Spectrum at the Testes without Shield for Chest Exam. 
Vertical ticks indicate mean energy. Field size is in cm, 
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Figure 61. Spectrum at the Right Ovary for Lower Spine Exam. Vertical 
ticks indicate mean energy. Field size 1s in cm. D is 
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Figure 62. Spectrum at the Right Ovary for Full Spine Exam. Vertical 
ticks indicate mean energy. Field size is in cm. D is 
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Figure 63. Spectrum at the Right Ovary for Abdominal Exam. Vertical 
ticks indicate mean energy. Field size is in cm. D is 
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Figure 64. Spectrum at the Right Ovary for Shoulder Exam. Vertical 
ticks indicate mean energy. Field size is in cm. D is 
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Figure 65. Spectrum at the Right Ovary for Upper G.I. Exam. Vertical 
ticks indicate mean energy. F:ield size is in cm. D is 
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Figure 66. Spectrum at the Right Ovary for Pelvic Exam. Vertical ticks 
indicate mean energy. Field size is in cm. D is the 
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Spectrum at the Right Ovary for Chest Exam. Vertical ticks 
indicate mean energy. Field size is in cm. D is the ab-
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Figure 68. Spectrum at the Thyroid Gland for Lower Spine Exam. Vertical 
ticks indicate mean energy. Field size is in cm. D is the 
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Figure 69. Spectrum at the Thyroid Gland for Full Spine Exam. Vertical 
t icks indicate mean energy. Field size is in cm. D is the 
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Figure 70. Spectrum at the Thyroid Gland for Abdominal Exam. Vertical 
ticks indicate mean energy. Field size is in cm. D is the 
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Figure 71. Spectrum at the Thyroid Gland for Shoulder Exam. Vertical 
ticks indicate mean energy. Field size is in cm. D is the 
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Figure 72. Spectrum at the Thyroid Gland for Upper G.I. Exam. Vertical 
ticks indicate mean energy. Field size is in cm. D is the 
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Figure 73. Spectrum at the Thyroid Gland for Pelvic Exam. Vertical 
ticks indicate mean energy. Field size is in cm. D is the 
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Figure 74. Spectrum at the Thyroid Gland for Chest Exam. Vertical 
ticks indicate mean energy. Field size is in cm. D is the 
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Figure 75. Spectrum at the Heart Region for Lower Spine Exam. Vertica' 
ticks indicate mean energy. Field size is in cm. D is the 
absorbed dose per unit current per unit time (mrad/mA-s). 
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Spectrum at the Heart Region for Full Spine Exam. Vertical 
ticks indicate mean energy. Field size is in cm. D is the 
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Spectrum at the Heart Region for Abdominal Exam. Vertical 
ticks indicate mean energy. Field size is in cm. D is the 
absorbed dose per unit current per unit time (mrad/mA-s). 
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ticks indicate mean energy. Field size is in cm. D is the 
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Spectrum at the Heart Region for Upper G.I. Exam. Vertical 
ticks indicate mean energy. Field size is in cm. D is the 
absorbed dose per unit current per unit time (mrad/mA-s). 
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Spectrum at the Heart Region for Pelvic Exam. Vertical ticks 
indicate mean energy. Field size is in cm. D is the ab-
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Figure 81. Spectrum at the Heart Region for Chest Exam. Vertical ticks 
indicate mean energy. Field size is in cm. D is the ab-
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Spectrum at the Fifth Lumbar Vertebra for Lower Spine Exam, 
Vertical ticks indicate mean energy. Field size is in cm. 
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Spectrum at the Fifth Lumbar Vertebra for Full Spine Exam, 
Vertical ticks indicate mean energy. Field size 1s in cm. 
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Figure 84. Spectrum at the Fifth Lumbar Vertebra for Abdominal Exam. 
Vertical ticks indicate mean energy. Field size is in cm. 
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Spectrum at the Fifth Lumbar Vertebra for Shoulder Exam. 
Vertical ticks indicate mean energy. Field size is in cm. 
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Spectrum at the Fifth Lumbar Vertebra for Upper G.I. Exam. 
Vertical ticks indicate mean energy. Field size is in cm. 
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Spectrum at the Fifth Lumbar Vertebra for Pelvic Exam. 
Vertical ticks indicate mean energy. Field size is in cm. 
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Figure 88. Spectrum at the Fifth Lumbar Vertebra for Chest Exam. 
Vertical ticks indicate mean energy. Field size is in cm. 
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Spectrum at the Thoracic Spine for Lower Spine Exam. 
Vertical ticks indicate mean energy. Field size is in cm. 
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Spectrum at the Thoracic Spine for Full Spine Exam. 
Vertical ticks indicate mean energy. Field size is in cm. 
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Spectrum at the Thoracic Spine for Abdominal Exam. 
Vertical ticks indicate mean energy. Field size is in cm, 
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Figure 92. Spectrum at the Thoracic Spine for Shoulder Exam. 
Vertical ticks indicate mean energy. Field size is in 
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Spectrum at the Thoracic Spine for Upper G.I. Exam. 
Vertical ticks indicate mean energy. Field size is in cm. 
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Spectrum at the Thoracic Spine for Pelvic Exam. Vertical 
ticks Indicate mean energy. Field size 1s 1n cm. D 1s 
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Figure 95. 
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Spectrum at the Thoracic Spine for Chest Exam. Vertical 
t icks indicate mean energy. Field size is in cm. D is 
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Figure 96. Spectrum at the Eye Region for Lower Spine Exam. Vertical 
ticks indicate mean energy. Field size is in cm. D is 
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Spectrum at the Eye Region for Full Spine Exam. Vertical 
ticks indicate mean energy. Field size is in cm. D is 
the absorbed dose per unit current per unit time (mrad/mA-s). 
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Figure 98. Spectrum at the Eye Region for Abdominal Exam. Vertical 
ticks indicate mean energy. Field size is in cm. D is 
the absorbed dose per unit current per unit time (mrad/mA-s). 
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Figure 99. Spectrum at the Eye Region for Shoulder Exam. Vertical 
ticks indicate mean energy. Field size 1s in cm. D is 
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Spectrum at the Eye Region for Shoulder Exam (with 28 x 44 
cm Field). Vertical ticks indicate mean energy. Field size 
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Spectrum at the Eye Region for Upper G.I. Exam. Vertical 
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igure 102. 
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Spectrum at the Eye Region for Pelvic Exam. Vertical ticks 
indicate mean energy. Field size is in cm. D is the absorbed 
dose per unit current per unit time (mrad/mA-s). 
APPENDIX B 
EFFECT OF FIELD SIZE 
Presented in this Appendix are the comparisons of the spectra 
acquired for the lower spine, full spine, and abdominal examinations 
for six detector locations including the testes, right ovary, thyroid, 
lens of the eye, fifth lumbar vertebra, and thoracic spine regions. 
These comparisons are presented to show the effect of field size on 
the spectrum. The lower spine, full spine, and abdominal exams all 
have the same beam center, and their field sizes are 10 x 10 cm, 
10 x 44 cm, and 36 x 44 cm, respectively (see Figures 22-24). 
191 
192 
X 1 0 4 
1.801 
DETECTOR L O C A T I O N - EYE R E G I O N 
L-60 ALL CASES 
'36 X 44 

















— 80 KVCP 
D=8.12E-03 













20 30 40 50 60 70 
ENERGY ( K E V ) 
b. 
80 90 100 
Spectrum at the Eye Region for Chest Exam. Vertical ticks 
indicate mean energy. Field size 1s in cm. D is the ab-
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gure 104. Spectrum at the Testes as a Function of Field Size ~ 60 kVcp. 
Vertical ticks indicate mean energy. Field size is in cm. 
D is the absorbed dose per unit current per unit time (mrad/mA-s) 
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Spectrum at the Testes as a Function of Field Size -- 80 kVcp 
Vertical ticks indicate mean energy. Field size is in cm. 
D is the absorbed dose per unit current per unit time 
(mrad/mA-s). 
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Figure 106. Spectrum at the Testes as a Function of Field Size — 
100 kVcp. Vertical ticks Indicate mean energy. Field size 
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Figure 107. Spectrum at the Right Ovary as a Function of Field Size — 
60 kVcp. Vertical ticks indicate mean energy. Field size 
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Spectrum at the Right Ovary as a Function of Field Size --
80 kVcp. Vertical ticks indicate mean energy. Field size 
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Spectrum at the Right Ovary as a Function of Field Size — 
100 kVcp. Vertical ticks Indicate mean energy. Field size 
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Spectrum at the Thyroid as a Function of Field Size --
60 kVcp. Vertical ticks indicate mean energy. Field size 
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Spectrum at the Thyroid as a Function of Field Size — 
80 kVcp. Vertical ticks indicate mean energy. Field size 
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Spectrum at the Thyroid as a Function of Field Size --
100 kVcp. Vertical ticks indicate mean energy. Field size 
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Spectrum at the Fifth Lumbar Vertebra as a Function of 
Field Size — 60 kVcp. Vertical ticks indicate mean 
energy. Field size is 1n cm. D is the absorbed dose per 
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Spectrum at the Fifth Lumbar Vertebra as a Function of 
Field Size — 80 kVcp. Vertical ticks indicate mean 
energy. Field size is in cm. D is the absorbed dose 
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Spectrum at the Fifth Lumbar Vertebra as a Function of 
Field Size — 100 kVcp. Vertical ticks indicate mean 
energy. Field size is in cm. D is the absorbed dose 
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Figure 116. Spectrum at the Thoracic Spine as a Function of Field 
Size -- 60 kVcp. Vertical ticks indicate mean energy, 
Field size is in cm. D is the absorbed dose per unit 
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Spectrum at the Thoracic: Spine as a Function of Field 
Size ~ 80 kVcp. Vertical ticks indicate mean energy, 
Field size is in cm. D is the absorbed dose per unit 
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Figure 118. Spectrum at the Thoracic Spine as a Function of Field 
Size — 100 kVcp. Vertical ticks Indicate mean energy. 
Field size 1s in cm. D is the absorbed dose per unit 
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Spectrum at the Eye Region as a Function of Field Size • 
60 kVcp. Vertical ticks indicate mean energy. Field 
size Is in cm. D is the absorbed dose per unit current 
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Spectrum at the Eye Region as a Function of Field Size — 
80 kVcp. Vertical ticks indicate mean energy. Field 
size is in cm. D 1s the absorbed dose per unit current 
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Figure 121. Spectrum at the Eye Region as a Function of Field Size • 
100 kVcp. Vertical ticks indicate mean energy. Field 
size is in cm. D is the absorbed dose per unit current 
per unit time (mrad/mA-s). 
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